Introduction
============

Vitamin D is a steroid hormone that modulates a wide range of molecular and cellular functions, most readily recognized are its beneficial effects on musculoskeletal parameters. Rickets and osteomalacia represent short-term latency manifestation of vitamin D deficiency and osteoporosis the long-term latency manifestation of more subtle chronic deficiencies.[@R1]^,^[@R2] An increasing body of evidence also supports non-traditional, extra-skeletal, benefits of vitamin D on the immune system, fuel metabolism, cardiovascular system diseases and cancer.[@R2]^-^[@R5] In addition, associations with decreased mortality have been described.[@R6]

While rickets is almost eradicated in western populations, its prevalence remains unacceptably high in Asia, Africa and the Middle East and resurgence is also registered in ethnic minority groups in some Northern European countries.[@R7]^,^[@R8] Conversely, hypovitaminosis D is prevalent worldwide, but is again most notable in Asia and surprisingly the Middle East, despite its plentiful sunshine.[@R1]^,^[@R3] Although such observations stem mostly from non-population based studies, they have for the most part been consistent across reviews over the last decade.[@R9]^-^[@R14] Such findings are explained by the prevalence of specific risk factors for hypovitaminosis D in this region. These include the classic predictors, in addition to conservative concealed clothing style in women in general and in men from gulf countries in particular. The, lack of governmental regulation for food fortification with vitamin D in the region has also been noted

The aim of this paper is to systematically review the prevalence of rickets, osteomalacia and hypovitaminosis D, in the Middle East and North Africa (MENA) region, evaluate relevant predictors and describe the impact of low vitamin D status on relevant outcomes in studies from the region. Implications of the vitamin D guidelines issued by the Institute of Medicine and the Endocrine Society in 2011 will be put in perspective taking into consideration the status of vitamin D in the MENA.[@R15]^,^[@R16]

Methods
=======

Definition of Middle East North Africa region
---------------------------------------------

According to the UNICEF, the MENA is composed of 20 countries: Algeria, Bahrain, Lebanon, Egypt, Djibouti, Syria, Occupied Palestinian Territory, Iran, Iraq, Yemen, Tunisia, Sudan, UAE, Saudi Arabia, Jordan, Oman, Libya, Kuwait, Morocco and Qatar.[@R17] According to the World Bank, countries in the Middle East include United Arab Emirates (UAE), Syria, Qatar, Lebanon, Kuwait, Saudi Arabia, Jordan, Iraq, Iran, Yemen, Oman and Bahrain; and in North Africa Algeria, Egypt, Libya, Morocco, Tunisia and Sudan.[@R18]

Literature search methodology
-----------------------------

A systematic review of the literature was implemented targeting the following keywords: vitamin D, vitamin D deficiency or rickets, osteomalacia, conducted separately for each of the individual countries listed above for the Middle East North Africa region (MENA). Each of these keywords were searched on OVID Medline as MeSH terms and also as synonyms or related terms to achieve a comprehensive literature review. The OVID Medline interface was utilized as it allows searching for related MeSH-terms, explode functions, keyword searching in title, abstract and subject headings, adjacency and publication types, in addition to Boolean operators (and, or**)** and truncation, to identify as many relevant articles as possible. OVID Medline search was conducted from year 1946 until the third week of September, 2012, then tailored to years 2000-Dec 2012 (see Appendix S1). The exact procedure used for every country of the MENA region is detailed in Appendix S1. A PubMed search was also done using the key terms for each of the countries of interest to capture the most recent publications entered into PubMed, not yet indexed in OVID Medline. The following search was entered for each of the countries of the MENA region, the example for Lebanon was: (vitamin D OR rickets OR osteomalacia) AND (Lebanon OR Lebanese). The Embase database was also used to capture a more comprehensive view on studies done in the Middle Eastern region. We also used data compiled in the 2011 International Osteoporosis Foundation (IOF) Middle East Africa Osteoporosis Audit,[@R19] and additional studies and reviews detailed in the papers retrieved and available in authors\' libraries.

Search yield and manuscripts reviewed
-------------------------------------

A total of 2323 hits were identified from Embase, PubMed and OVID Medline for all the countries, with the exception of Djibouti and Libya, that had no hits. Three screening phases were implemented for identifying relevant articles. The first phase involved screening the titles and abstracts and resulted in 362 manuscripts between 1946 and 2012. The second phase involved deleting studies published before year 2000, thus resulting in 295 papers. The third phase involved retrieving and reviewing the full-text for all 295 papers, of which only 176 where retrievable and these were scored for quality measures based on specific criteria: type of the study (population based yes or no), sample size (n \> 100 yes or no), whether the vitamin D assay was specified (yes or no), whether predictors were specified (yes or no) and exclusion criteria were specified (yes/no). Each criterion received a score of 1 if answered positively and articles were sorted into four quality categories: very good for score ≥ 4/5, good for score 3/5, fair for score 2/5 or poor if score 1/5. The large majority of the 295 retrieved papers were from Iran (n = 86), Saudi Arabia (n = 47), UAE (n = 21), Egypt (n = 20), followed by Lebanon, Kuwait, Jordan, Qatar and Morocco Jordan (n = 11−16 each) and Yemen, Tunisia, Iraq, Bahrain, Oman (n = 1−5 each). Out of the total of 176 studies, 109 studies characterized as of very good or good quality are detailed in this review.

For association and intervention studies, as well as reports on rickets or osteomalacia, rating score was not applied and all relevant studies were examined. Titles and abstracts for reviews on osteomalacia retrieved prior to 2000 (n = 338) were screened and all relevant reviews in the MENA, in addition to those on hypovitaminosis D[@R9]^-^[@R11] were used to summarize information for the period preceding year 2000.

Interpretation of results from papers on vitamin D and cut-offs used to determine desirable levels
--------------------------------------------------------------------------------------------------

Serum 25 hydroxy-vitamin D \[25(OH)D\] 25(OH)D level is the best indicator of vitamin D nutritional status. The importance of variations in serum 25(OH)D assays and the lack of their standardization has been recently recognized.[@R20]^,^[@R21] Furthermore, there is no universal agreement on what constitutes a desirable level to optimize musculoskeletal health in elderly Caucasians,[@R15]^,^[@R16] let alone optimal levels across the lifecycle, for other ethnic groups or targeting other major chronic diseases outcomes. Findings from any paper on vitamin D, have to therefore be interpreted in this context. Results for serum 25(OH)D are reported in ng/ml, to convert to from ng/ml to nmol/L multiply the value by 2.5.

Magnitude of the Problem and Predictors of Low Vitamin D Status
===============================================================

Rickets and osteomalacia
------------------------

Rickets and osteomalacia are conditions that can result from severe vitamin D deficiency, hypophosphatemia or mineralization defects. This paper focuses on those resulting from vitamin D deficiency, best captured by measurement of serum 25 hydroxy-vitamin D \[25(OH)D\] level. Rickets is a childhood condition caused by serious vitamin D deficiency and is characterized by soft and weak bones, slowed growth and skeletal development and convulsions. Rickets, by definition, is a disorder which begins in childhood. If this problem occurs later in life it is known as osteomalacia. In a review on rickets worldwide, covering 30 y from 1968--1998, Prentice et al. noted that Asia, the Middle East and Africa, a region spanning latitudes from 5° to 40° North, registered the highest rates. The reported rates for clinical or radiological rickets were 70% in Mongolia (1998), 66% in Tibet (1994), 44% in Ethiopia (1987), 27% in Yemen (1987), 15% in Iran (1975), 10% in Turkey (1994) and 9% in Nigeria (1998), compared with 1.6% in Manchester minorities mostly Pakistanis.[@R7]^,^[@R8] Similarly, a review by our group underscored the lack of adequate population based studies and reported rates to be 10--100 folds higher than those in western populations.[@R11] These include a prevalence of 27% in children \< 5 y in North Yemen, 10% in a field sample from rural Egypt, 1% Kuwait if \< 2yrs (1981−86), 0.5% of Saudis \< 2 y (1997--1999) and 6% in Turkey in 1998 down to \< 1% in 2008, the latter following a National Vitamin D supplementation program.[@R11] Rickets accounted for a substantial number of pediatric hospital admissions, 50% of children hospitalized with pneumonia in Yemen, 11% of infant's admissions with acute illness in Jordan, 6.5% of newborn admissions in Kuwait and 1.8% of pediatric admissions in 1986--88 in Saudi Arabia.[@R9]^,^[@R11] Non-skeletal manifestations of rickets included convulsions in 4−79% of patients, acute chest infections and asthmatic bronchitis in 66% of 500 cases in Saudi Arabia, broncho-pneumonia in 43% of 200 Iranian children and 44% of 250 children from Kuwait. An acute infection or respiratory diseases were the presenting manifestation in 20--60% of cases presenting with rickets in smaller studies from Turkey, Egypt, Jordan and Saudi Arabia, while gastroenteritis accounted for 8--56% of reasons for admission in hospitals in Middle East. Dilated cardiomyopathy was reported in three infants from Asia, one from Turkey and two from UAE.[@R11] Predictors of rickets included, low maternal vitamin D status, prolonged breast feeding, low socioeconomic status (SES), educational level and crowding. It has been recognized that primary vitamin D deficiency does not adequately describe nutritional rickets explained in some African, Middle Eastern and Asian countries and that concomitant low calcium intake and possibly disturbances of phosphate metabolism, renal compromise and iron deficiency may also play an important role in the pathophysiology of the disease.[@R9]

In our current search, we retrieved 13 publications on rickets, but only 8 were on nutritional rickets. Case series were published in Iran, Saudi Arabia, Kuwait, United Arab Emirates, Qatar and Egypt, with sample sizes ranging 21 to 283 subjects and age ranging from infants all the way to adolescents, with the majority being infants and toddlers.[@R22]^-^[@R30] In a study of 98 rachitic children from Egypt and Turkey, mean age 11.7 y, mean 25(OH)D was 14.3 (± 11.2) ng/ml in patients from Egypt and 10.1 (± 7.9) ng/ml in Turkey, compared with mean levels above 20 ng/ml in controls, underscoring a combined etiology that includes insufficient calcium intake, in the pathophysiology of rickets and possibly other factors, especially in Egypt.[@R29] Similarly, in a small study of 16 Emirati children from Abu Dhabi (24°), nutritional rickets from vitamin D deficiency was reported in eight subjects, with a mean 25(OH)D of 7(± 2) ng/ml and a mixed etiology with combined calcium deficiency in the rest with a mean 25(OH)D of 17 (± 8) ng/ml.[@R31] Common risk factors included multiparity, prolonged breast feeding, delayed intake of semi-solids, maternal education and complete wrapping of the child.[@R28]

Osteomalacia, the adult manifestation of rickets, may be asymptomatic and go undetected, thus making true prevalence studies very difficult. The diagnosis is usually made on basis of the classic clinical profile of bone pain, fractures and proximal myopathy, combined with confirmatory laboratory tests including a low 25(OH)D, usually below 5--10 ng/ml (25--50 nmol/L), low serum calcium and phosphate levels and a high alkaline level . However, the patient may not have hypocalcemia due to correction of serum calcium level from secondary hyperparathyroidism. Moreover, hypovitaminosis D can be misdiagnosed as fibromyalgia, chronic fatigue syndrome or simply depression.[@R32]^,^[@R33] The above 25(OH)D cut-offs are not diagnostic of osteomalacia, as demonstrated in a study in Caucasian subjects.[@R34] We are unaware of such studies in MENA. Convulsions and hypocalcemic cardiomyopathy are also very rare manifestation of severe hypocalcemia from rickets or any other causes.[@R35] To-date, most publications on osteomalacia are limited to case reports or case series, made on basis of a clinical diagnosis.[@R36]^,^[@R37] The condition can mimic osteoporosis, with severe bone demineralization due to severe vitamin D deficiency, hyperparathyroidism, vertebral compression fractures, T-scores ranging from -5 to -4, with normalization after aggressive vitamin D therapy.

Hypovitaminosis D
-----------------

Despite limitations caused by the lack of methodological standardization, in general, a serum 25(OH)D at concentration less than25 nmol/L (10 ng/mL) is a useful marker of the risk of clinical deficiency, but the terminology and cut-offs used to define less than desirable vitamin D status is controversial. It includes terms such as insufficiency, inadequate level, sub-optimal level and hypovitaminosis D and may result in subclinical conditions with chronic latent manifestations, the most recognized of which is osteoporosis. The 25(OH)D cut-offs to define this condition vary and have most recently been framed by the 2011 desirable levels of the Institute of Medicine Report set at 20 ng/ml (50 nmol/L),[@R16] and the Endocrine Society Guidelines set at 30 ng/ml (75 nmol/L).[@R15] Most studies have however predated these recommendations and used variable cut-offs.

In a review conducted by the nutrition working group of the IOF, hypovitaminosis defined as 25 (OH)D level below 30 ng/ml (75 nmol/L) was prevalent in all regions of the world, whereas levels below 10 ng/ml (25 nmol/L) were most common in South Asia and the Middle East. Predictors of low 25(OH)D levels included older age, female sex, higher latitude, winter season, darker skin pigmentation, less sun exposure, dietary habits and absence of vitamin D fortification.[@R12] The high prevalence of hypovitaminosis D worldwide, and not only in risk groups, was again underscored in a recent review, Asia and the Middle East being at particular risk, albeit with high variability between studies within the ME.[@R13]^,^[@R14] The latest attempt at a global representation of vitamin D status in healthy populations, commented on the lack of representative studies, large gaps in information in children, adolescents worldwide and in adults in Central and South America, as well as Africa.[@R14]

One of the original studies on hypovitaminosis D in the Middle East was conducted in apparently healthy 104 male Saudi university students, who had a mean 25(OH)D of 12.8 (± 6.3)ng/ml with 35% \< 10 ng/ml[@R38]. The high prevalence of hypovitaminosis D in Saudi subjects has been validated in numerous studies. [Table 1](#T1){ref-type="table"} summarizes key findings from studies of good or very good quality retrieved from our search, for adults from the MENA region.[@R39]^-^[@R81] The overwhelming majority of studies revealed 25(OH)D levels in the low teens \[25(OH)D 10−15 ng/ml\], even considering population-based studies. Consistent predictors across these studies for lower values were age, albeit with differing findings, some studies showing older age to be a risk factor,[@R57]^,^[@R67]^,^[@R69] while others point to younger age,[@R41]^,^[@R42]^,^[@R77] female gender in adults[@R41]^,^[@R61]^,^[@R63]^,^[@R72]^,^[@R75]^,^[@R82] and children,[@R83]^-^[@R89]winter season, sunlight exposure and veiling,[@R40]^,^[@R41]^,^[@R44]^,^[@R56]^,^[@R60]^,^[@R63]^,^[@R66]^,^[@R75]^,^[@R78]^,^[@R81]^,^[@R90]^,^[@R92]except in some studies from gulf countries where summer registers lowest values in studies from the United Arab Emirates,[@R75]^,^[@R77] pollution,[@R43] low calcium or vitamin D dietary intake,[@R67]^,^[@R77]^,^[@R80]^,^[@R81]^,^[@R90]^,^[@R92] and exclusive breast feeding in infants[@R88]. Other predictors included high BMI and /or increased adiposity,[@R39]^,^[@R60]^,^[@R66]^-^[@R68]^,^[@R72]^,^[@R93] and lower SES status or educational level[@R44]^,^[@R60]^,^[@R64]^,^[@R68]^,^[@R80]^,^[@R83].The impact of menopause was not consistent across studies, whereas premenopausal women had higher levels in the study from Saudi Arabia,[@R67] the opposite was found in UAE.[@R77][Table 1](#T1){ref-type="table"} details studies conducted in adults, [Table 2](#T2){ref-type="table"} in children, [Table 3](#T3){ref-type="table"} in mothers-neonates, by country, and highlights are underscored here-in.

###### **Table 1.** Overview of Studies on 25(OH) D Values in Adults in Middle East and North Africa

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country                         Author/Yr                        Sampling Method\                                                  N Gender/ Age                Exclusion criteria specified   Assay type/ Manufacturer    Season Yr                          Predictors for low 25(OH)D                     25(OH)D Level Mean ng/ml % below cut-off
                                                                   City (Latitude)                                                                                                                                                                                                                             
  ------------------------------- -------------------------------- ----------------------------------------------------------------- ---------------------------- ------------------------------ --------------------------- ---------------------------------- ---------------------------------------------- ----------------------------------------------
  **Middle East**                                                                                                                                                                                                                                                                                              

  **Iran**                        Baradaran et al. 2012[@R39]      Hospital based\                                                   259 ♀♂\                      Yes                            EIA/IDS                     NA 2010                            High adiposity,\                               12 ± 6\
                                                                   Iran (32°N)                                                       20--64 y                                                                                                                   high BMI                                       Median: 10

                                  Kashi et al. 2011[@R40]          Telephone population based Sari (37°N)                            232 ♀,118♂\                  Yes                            ELISA/DRG                   End of summer\                     High humidity climate, winter                  Summer: 13.4 ± 13\
                                                                                                                                     11--69 y                                                                                and winter NA                                                                     Winter: 11.7 ± 11

                                  Hovsepian et al. 2011[@R41]      Outpatient clinic\                                                243 ♂, 868 ♀\                Yes                            RIA/ Biosource              Autumn/ Winter-Spring/ Summer NA   Young age, women                               Median Spring: 21 (2--300)\
                                                                   Isfahan (32°N)                                                    20--80 y                                                                                                                                                                  Median Summer: 18 (3--208)\
                                                                                                                                                                                                                                                                                                               Median Autumn: 19 (1.5--425)\
                                                                                                                                                                                                                                                                                                               Median Winter: 17 (2--281)\
                                                                                                                                                                                                                                                                                                               27% \< 10, 24% 10--20, 20% 20--30

                                  Kaykhaei et al. 2010[@R42]       Population based\                                                 431 ♂, 562♀\                 No                             CIA/ DiaSorin               June -Aug 2008                     Younger age                                    13.8\
                                                                   Zahedan (30°N)                                                    20--88 y                                                                                                                                                                  95% \< 30 85% \< 20\
                                                                                                                                                                                                                                                                                                               10% 20--30 5% 30--150

                                  Hosseinpanah et al. 2010[@R43]   Clustered sampling Tehran (35° N),\                               200♀\                        Yes                            EIA/DRG                     Sept 2007                          Air pollution                                  Ghazvinian: ♀ 18 ± 11\
                                                                   Ghazvin (36°N)                                                    20- 55 y                                                                                                                                                                  Tehranian: ♀ 13 ± 7\
                                                                                                                                                                                                                                                                                                               Tehranian: 36% \< 10 54% 10--20\
                                                                                                                                                                                                                                                                                                               Ghazvinian: 31% \< 10 32% 10--20

                                  Maddah et al. 2009[@R44]         Clustered sampling\                                               427 ♀ Urban\                 No                             Commercial kit/ BioSource   Oct 2004-Feb 2005                  Low education, urban living                    ♀ Urban: 18.5 ± 13.5\
                                                                   Guilan (37°N)                                                     219 ♀ Rural\                                                                                                                                                              ♀ Rural: 22.9 ± 13.8
                                                                                                                                     51--92 y                                                                                                                                                                  

                                  Masoompour et al. 2008[@R45]     Clustered sampling\                                               520 ♂\                       Yes                            IRMA/IDS                    Jan-Mar 2001                       NA                                             14 ± 6.8\
                                                                   Shiraz (30°N)                                                     20--74 y                                                                                                                                                                  34% ≤ 10

                                  Hosseinpanah et al. 2008[@R46]   Population based study Tehran (35°N)                              245 p.m.♀\                   Yes                            RIA/IDS                     NA                                 NA                                             5% \< 10 38% 10--20\
                                                                                                                                     40--80 y                                                                                                                                                                  43% \< 20 25% \> 32

                                  Hashemipour et al. 2006[@R47]    Clustered sampling\                                               1210 ♂♀\                     Yes                            RIA/IDS                     NA                                 NA                                             12.9 ± 16.5\
                                                                   Tehran (35°N)                                                     20--69 y                                                                                                                                                                  9% ≤ 5 56% 5--10

                                  Rassouli et al. 2001[@R48]       Densitometry center Tehran (35°N)                                 73 p.m.♀\                    Yes                            HPLC                        Feb-June 2000                      NA                                             Winter: 13.3 ± 5.0\
                                                                                                                                     49--63 y                                                                                                                                                                  Spring: 18.3 ± 12\
                                                                                                                                                                                                                                                                                                               36% \< 12

  **Occupied Palestine/Israel**   Saliba et al. 2012[@R49]         Population Based CHF covers \> 50% of Israeli population (31°N)   198,834♀♂\                   Yes                            CIA/ Diasorin               Jan-Dec 2009                       Female gender, winter, adults, Arabs \> Jews   Summer-Autumn: 22.52 ± 9.8\
                                                                                                                                     Median 60 y                                                                                                                                                               Winter-Spring: 18.72 ± 9.4\
                                                                                                                                                                                                                                                                                                               14% \< 10 31% \< 15\
                                                                                                                                                                                                                                                                                                               50% \< 20 16% \> 30

                                  Saliba et al. 2012[@R50]         Population Based                                                  2571♂, 6310♀\                Yes                            CIA / Diasorin              Jan 2008-Sep 2011                  Female gender                                  First test: 20.68 ± 9.6 50% \< 20\
                                                                                                                                     56.1 ± 17.6 y (1st test)\                                                                                                                                                 Last test: 22.68 ± 9.88 41% \< 20\
                                                                                                                                     57.6 ± 17.7 y (Last test)                                                                                                                                                 \*First and last test done in the same month

  **Middle East**                                                                                                                                                                                                                                                                                              

                                  Saliba et al. 2012[@R51]         Population Based                                                  182, 152 ♀♂\                 No                             CIA/ Diasorin               Jan 2008 - Dec 2009                History of diabetes\                           25% ≤ 13ng/ml, mean 9.3 ± 2.7\
                                                                                                                                     VitD ≤ 13: 59.4 ± 17.4yrs\                                                                                                 History of Cardiovascular disease              25% 13--20 ng/ml, mean 16.8 ± 1.8\
                                                                                                                                     VitD13--20: 61 ± 16.1 y\                                                                                                                                                  25% 20--26ng/ml, mean 22.8 ± 1.8\
                                                                                                                                     VitD20--26: 61.1 ± 16 y\                                                                                                                                                  25% \> 26ng/ml, mean 32.6 ± 6.4
                                                                                                                                     VitD \> 26: 59.9 ± 17.1yrs                                                                                                                                                
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                     Tsur et al.\                         Institution based Jerusalem (31.7°N)     74♂ students\                                **Yes**   **RIA /DLS**        **Mar-Apr NA**                          **Low sun exposure, traditional clothing**                                                                      **(A) 8.9 ± 3.6 100% \< 20 65% \< 10**\
                     2011[@R52]                                                                    (A) Ultra-orthodox Indoors 20.1 ± 0.6yrs\                                                                                                                                                                                          **(B) 10.2 ± 5.7 91% \< 20 65% \< 10**\
                                                                                                   (B) Ultra-Orthodox Outdoors 33.0 ± 4.2yrs\                                                                                                                                                                                         **(C) 21.7 ± 10.4 51% \< 20 12% \< 10**
                                                                                                   **(C) Religious 19 ± 2.0yrs**                                                                                                                                                                                                      
  ------------------ ------------------------------------ ---------------------------------------- -------------------------------------------- --------- ------------------- --------------------------------------- --------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------
                     **Saliba et al. 2011**[@R53]         **Population Based**\                    **19,172 ♂♀**\                               **No**    **CIA/ Diasorin**   **Jan-Dec 2009**                        **Renal Failure**                                                                                               **Renal Failure: 22.8 ± 11**\
                                                          **(31°N)**                               **63.7 ± 15.5 y**\                                                                                                                                                                                                                 **Normal Function: 25.32 ± 10.64**
                                                                                                   **Normal:19,172**\                                                                                                                                                                                                                 
                                                                                                   **Renal failure:5449**                                                                                                                                                                                                             

                     Steinvil et al. 2011[@R54]           Retrospective\                           26,699♀ 55 ± 15 y\                           No        RIA /Diasorin       Jan-Dec 2001--2008                      Low sun exposure                                                                                                ♂ 23.22 ± 10.1 79% \< 30\
                                                          Population based (31°N)                  8175♂ 55 ± 17 y                                                                                                                                                                                                                    ♀ 22.7 ± 9.9 78% \< 30

                     Oren et al.\                         NA\                                      100♀, 95♂\                                   No        CIA/ Diasorin       Feb-Jan NA                              Older Age, Ashkenazi \> Sephardic \> Arab                                                                       22.9 ± 10.1\
                     2010[@R55]                           (31°N)                                   \< 5yrs - \> 50yrs                                                                                                                                                                                                                 78% \< 30

  **Jordan**         Nichols et al. 2012[@R56]            National micronutrient survey\           2032 ♂ 15--49 y                              No        LC-MS/MS            Mar-Apr 2010                            Urban living, veiling                                                                                           Median: 11 96% \< 20 60% \< 12\
                                                          Jordan (31°N)                                                                                                                                                                                                                                                               No cover n = 98 40% \< 12\
                                                                                                                                                                                                                                                                                                                                      Scarf/hijab n = 1842 62% \< 12\
                                                                                                                                                                                                                                                                                                                                      Niqab (full) n = 73 68% \< 12

                     Batieha et al. 2011[@R57]            National population based\               1128 ♂, 3462 ♀\                              No        RIA/ Biosource      July--Oct-Nov 2009                      Older age, middle and south region, winter season, low altitude, sunscreen use, indoor work, urban, veiling     ♂ 73.3 ± 29.3\
                                                          Jordan (31°N)                            \> 18 y                                                                                                                                                                                                                            94% ≥ 30 4% 20--29.9 2% \< 20\
                                                                                                                                                                                                                                                                                                                                      ♀ 39.8 ± 20.7\
                                                                                                                                                                                                                                                                                                                                      63% ≥ 30 23% 20--29.9 14% \< 20

                     Mallah et al. 2011[@R58]             NA\                                      201 ♀, 99 ♂\                                 No        ELISA/IDS           November 2010                           Veiling                                                                                                         ♂18 ± 4 ♀ 12 ± 5\
                                                          Jordan (31°N)                            29--32 y                                                                                                                                                                                                                           Western Style: 16 ± 3\
                                                                                                                                                                                                                                                                                                                                      Hijab: 12.5 ± 2.5\
                                                                                                                                                                                                                                                                                                                                      Niqab: 11.4 ± 1.52

                     Mishal 2001[@R59]                    Hospital based\                          131 ♀, 23 ♂\                                 Yes       RIA/Diasorin        Summer: July--Sep Winter: Jan--Mar NA   Winter, veiling                                                                                                 3% \< 5 60% 5--12\
                                                          Jordan (31°N)                            18- 45 y                                                                                                                                                                                                                           Both seasons: 62% \< 12\
                                                                                                                                                                                                                                                                                                                                      Summer: 50% \< 12\
                                                                                                                                                                                                                                                                                                                                      Winter: 73% \< 12

  **Middle East**                                                                                                                                                                                                                                                                                                                     

  **Lebanon**        Gannaje-Yared et al. 2009[@R60]      Hospital based\                          151 Christians,\                             Yes       CIA/Nichols         July --Aug 2004\                        Dress code covering the arms, high BMI,\                                                                        19·5 ± 9·8
                                                          Lebanon (33°N)                           100 Muslims ♀\                                                             Feb-Mar 2005                            low education                                                                                                   
                                                                                                   50--87 y                                                                                                                                                                                                                           

                     Arabi et al. 2006[@R61]-2010[@R62]   Population based\                        286♀,157 ♂\                                  Yes       RIA/ IDS            Nov 2002-Mar2003                        Female gender                                                                                                   11.4 ± 4.9\
                                                          Beirut (34°N)                            65--85 y\                                                                                                                                                                                                                          ♀ 55% \< 10\
                                                                                                   Mean 73 y                                                                                                                                                                                                                          ♂ 37% \< 10

                     Gannaje-Yared et al. 2000[@R63]      Community centers\                       99 ♂, 217 Prem♀\                             Yes       RIA/ Incstar                                                Veiling,\                                                                                                       9.7 ± 7.1\
                                                          Bekaa, Beirut (34°N)                     30--50 y                                                                                                           ♀ rural living, ♂urban living,\                                                                                 31% (42% ♀, 7% ♂) \< 5\
                                                                                                                                                                                                                      low vit D intake                                                                                                73% (84%♀, 49% ♂) \< 12\
                                                                                                                                                                                                                                                                                                                                      80% (89% ♀, 51% ♂) \< 15

  **Saudi Arabia**   Ardawi et al. 2012[@R64]             Population based\                        834 ♂ 20--74yrs\                             Yes       CIA/ Liaison        Jun 2008-Jun 2009                       Heavy weight, summer, smoking, no education, sedentary lifestyle, low Vit D supplementation, low sun exposure   Total: 11.6 ± 6.45\
                                                          Health Care Centers\                     42.1 ± 13.9 y                                                                                                                                                                                                                      \< 50 y: 12.5 ± 7.01\
                                                          Jeddah (22°N)                                                                                                                                                                                                                                                               ≥ 50yrs: 10.7 ± 5.992\
                                                                                                                                                                                                                                                                                                                                      88% \< 20 10% ≥ 20--30

                     El Shafie et al. 2012[@R65]          Healthcare Center\                       50 married couples\                          Yes       ECLIA/Roche         Dec 2010 - Jan 2011                     Male gender, high physical activity, milk intake                                                                ♀ 8.5 ± 3.9 70% \< 10 98% \< 20\
                                                          Riyadh (25°N)                            ♂40.1 ± 7.4 y\                                                                                                                                                                                                                     ♂ 12.2 ± 5.5 40% \< 10 92% \< 20
                                                                                                   ♀30.6 ± 6.8yrs                                                                                                                                                                                                                     

                     Kanan et al. 2012[@R66]              Retrospective\                           1556 ♀\                                      Yes       HPLC                Jan- Dec 2009                           Low latitude, veiling,\                                                                                         13.3 ± 0.7 Prem Summer 80% \< 20\
                                                          out-patient clinics\                     Summer\                                                                                                            sun avoidance                                                                                                   11.4 ± 0.5 Prem Winter 85% \< 20\
                                                          Riyadh (25°N)                            44.4 ± 16.1 y\                                                                                                                                                                                                                     17.7 ± 0.9 p.m. Summer 68% \< 20\
                                                                                                   Winter\                                                                                                                                                                                                                            14.5 ± 0.6 p.m. Winter 76% \< 20
                                                                                                   46.1 ± 15.9 y                                                                                                                                                                                                                      

                     Ardawi et al.\                       Population based\                        1,172 healthy ♀\                             Yes       CIA/ Liaison        Jun 2008-Jun 2009                       Older age, high BMI, low sun exposure, poor dietary,\                                                           17.18 ± 12.19 (Prem)\
                     2011[@R67]                           Health Care centers\                     50.9 ± 12.6 y                                                                                                      low vit D supplementation, high WHR                                                                             13.32 ± 9.94 (PM)\
                                                          Jeddah (22°N)                                                                                                                                                                                                                                                               11% (6% Prem 14% PM) \< 5\
                                                                                                                                                                                                                                                                                                                                      46% (38% Prem 51% PM) \< 10\
                                                                                                                                                                                                                                                                                                                                      34% (34% Prem 34% PM) 10--20\
                                                                                                                                                                                                                                                                                                                                      9% (11% Prem 7% PM) 20--30\
                                                                                                                                                                                                                                                                                                                                      12% (16% Prem 8% PM) ≥ 30

                     Alissa et al.\                       Hospital based\                          122 p.m.♀\                                   Yes       RIA/ Diasorin       NA                                      High SES,\                                                                                                      9.6 ± 0.47 (Controls) 100% \< 20\
                     2011[@R68]                           Jeddah (22°N)                            46--70 y                                                                                                           heavy weight, low activity                                                                                      12.7 ± 1.06 (Osteopenic) 97% \< 20

  **Middle East**                                                                                                                                                                                                                                                                                                                     

                     Sadat-Ali et al.\                    Hospital based\                          400 Peak Bone Mass age group and ≥ 50yrs     Yes       RIA / Wallac        Feb -May 2008                           Older age                                                                                                       PBM age group\
                     2011[@R69]                           Al-Khobar (26°N)                                                                                                                                                                                                                                                            11% ♀ 10% ♂ \< 20\
                                                                                                                                                                                                                                                                                                                                      19% ♀ 19% ♂ 20--30\
                                                                                                                                                                                                                                                                                                                                      70% ♀ 71% ♂ \> 30\
                                                                                                                                                                                                                                                                                                                                      ≥ 50 y\
                                                                                                                                                                                                                                                                                                                                      19% ♀ 12% ♂ \< 20\
                                                                                                                                                                                                                                                                                                                                      36% ♀ 25% ♂ 20--30\
                                                                                                                                                                                                                                                                                                                                      45% ♀ 63% ♂ \> 30

                     El Sammak et al. 2011[@R70]          Hospital based\                          87 ♂, 52 ♀ blood donors                      Yes       CIA/ Liaison        Dec 2008- Mar2009                       Veiling                                                                                                         ♂ 10.1 ± 4.5\
                                                          Al-Khobar (26°N)                                                                                                                                                                                                                                                            ♀ 9.9 ± 4.5

                     El Sammak et al. 2010[@R71]          Hospital based\                          87 ♂ 30.0 ± 8.5yrs\                          Yes       CIA/Liaison         Dec 2008-Mar 2009                       NA                                                                                                              ♂ 10.1 ± 4.7\
                                                          Al-Khobar (26°N)                         52 ♀ 31.0 ± 7.2yrs                                                                                                                                                                                                                 ♀ 9.9 ± 4.5

                     Al-Elq et al.\                       Hospital based\                          200 ♂ 46.5 ± 14.6yrs 200 ♀ 42.6 ± 15.9yrs    Yes       RIA/Wallac          Feb-May 2008                            Older age, life Style, higher BMI ♂, lower BMI♀                                                                 ♂ 31.1 ± 10.7\
                     2009[@R72]                           Al-Khobar (26°N)                                                                                                                                                                                                                                                            ♀ 28.9 ± 10.7

                     Sadat-Ali et al.\                    Hospital based\                          100 ♂ 28.2 ± 4.5yrs\                         Yes       RIA/ Wallac         Feb-May 2008                            Low sun exposure                                                                                                Younger:\
                     2009[@R73]                           Al-Khobar (26°N)                         100 ♂ 59.4 ± 15.6yrs                                                                                                                                                                                                               Mean 16.6 ± 3.4 in those ≤ 20\
                                                                                                                                                                                                                                                                                                                                      Mean 25.4 ± 2.7 in those \> 20- \< 30\
                                                                                                                                                                                                                                                                                                                                      Older:\
                                                                                                                                                                                                                                                                                                                                      Mean 16.7 ± 3.4 in those ≤ 20\
                                                                                                                                                                                                                                                                                                                                      Mean 25.3 ± 3.3 in those \> 20--30

                     Al-Turki et al.\                     Hospital based\                          200 ♀\                                       Yes       RIA/ Wallac         Feb -May 2008                           Low sun exposure, low vit D diet                                                                                Group 1:\
                     2008[@R74]                           Al-Khobar (26°N)                         25--35 y (Group 1)\                                                                                                                                                                                                                11% \< 20 19% 21--29 70% \> 30\
                                                                                                   ≥ 50 y (Group 2)                                                                                                                                                                                                                   Group 2:\
                                                                                                                                                                                                                                                                                                                                      19% \< 20 36% 21--29 45% \> 30

  **UAE**            Al Anouti et al.\                    University based\                        208 ♀ 20.8 ± 4.0 y\                          No        HPLC                Oct 2009 138♀70 ♂\                      Low sun exposure, female gender                                                                                 Summer ♀ 8.3 ± 5.9\
                     2011[@R75]                           Al-Ain (24° N)                           70 ♂ 21.0 ± 4.6 y                                                          Apr 2010 70 ♀                                                                                                                                           ♂10.9 ± 6.2\
                                                                                                                                                                                                                                                                                                                                      Winter ♀ 12.5 ± 4.9

                     Dawodu et al.\                       Pilot Study\                             8 Healthy Arab ♀\                            Yes       HPLC                Sep --Nov 2001                          Decreased surface area of the skin exposed,\                                                                    Expose face, arms and hands 15 min/ d twice a week for 4 weeks\
                     2011[@R76]                           Al-Ain (24° N)                           20--30 y.                                                                                                          sun exposure\                                                                                                   pre-intervention 7.04\
                                                                                                                                                                                                                      low vit D intake                                                                                                post intervention 9.2

                     Saadi et al.\                        Local clubs,\                            175Prem 84PM♀\                               Yes       RIA/Diasorin        Jan 2003-Jun 2005                       Younger age,\                                                                                                   10.1 ± 4.3 Prem: 9.7 ± 4.2\
                     2006[@R77]                           primary care clinics, local hospitals\   Prem: 37.5 ± 9.5 y\                                                                                                low vit D intake, summer                                                                                        PM: 10.9 ± 4.5\
                                                          Al-Ain (24° N)                           PM: 58.3 ± 8.9 y                                                                                                                                                                                                                   All ♀ vit D \< 32\
                                                                                                                                                                                                                                                                                                                                      Apr 11.6 ± 5.2\
                                                                                                                                                                                                                                                                                                                                      Aug 7.2 ± 2.3

  **North Africa**                                                                                                                                                                                                                                                                                                                    

  **Morocco**                                                                                                                                                                                                                                                                                                                          

                     El Maghraoui et al. 2012[@R78]       Hospital based\                          178 p.m. ♀\                                  Yes       ECLIA/Roche         Summer 2010                             NA                                                                                                              15.8 ± 11.6\
                                                          Rabat (34°N)                             ≥ 50 y                                                                                                                                                                                                                             85% \< 30\
                                                                                                                                                                                                                                                                                                                                      66% \< 20\
                                                                                                                                                                                                                                                                                                                                      52% \< 10

                     Allali et al. 2009[@R79]             Hospital based Rabat (34°N)              415 ♀\                                       Yes       CIA/Diasorin        Summer NA                               Older age, lack of sun exposure, veiling, Ca intake \< 700 mg                                                   91% \< 30\
                                                                                                   24--77 y                                                                                                                                                                                                                           43% \< 15\
                                                                                                                                                                                                                                                                                                                                      4% \< 5

  **Tunisia**        Bahlous et al. 2009[@R80]            NA\                                      134 p.m. ♀ with osteoporosis                 Yes       HPLC                March--April 2004                       Osteoporosis                                                                                                    Fracture pts: 27.5 ± 15.1 51% \< 20\
                                                          Manouba (37°N)                                                                                                                                                                                                                                                              Non fracture pts: 21.3 ± 13 25% \< 20

                     Meddeb et al.\                       NA\                                      261♀ 128♂\                                   Yes       RIA/Incstar         Jan-March 2002                          Older age, veiling, high parity, postmenopausal                                                                 47% \< 15, 16% 5--10\
                     2005[@R81]                           Ariana (37°N)                            20--60 y                                                                                                                                                                                                                           36% 20--28 y\
                                                                                                                                                                                                                                                                                                                                      60% 50--59 y
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations in table listed here in alphabetical order: BMI: Body Mass Index; Ca: Calcium; CIA: Chemiluminescent Assay; EIA: Enzyme immunoassay; ELISA: Enzyme-linked immunosorbent Assay; ECLIA: Electrochemiluminescent Immunoassay; HPLC: High-performance liquid chromatography; IDS: Immunodiagnostic Systems; IRMA: Immunoradiometric Assay; LC-MS: Liquid Chromatography--Mass Spectrometry; NA: Not Available; PM: Post-Menopausal; Prem: Pre-Menopausal; PBM: Peak Bone Mass; RIA: Radioimmunoassay; SES: Socio-Economic Status; Vit: Vitamin ; WHR: Waist Hip Ratio ; Yrs: Years

###### **Table 2.** Overview of studies on 25(OH) D values in Children in Middle East

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country            Author/Yr                             Sampling Method City (Latitude)      N Gender/ Age                                  Exclusion criteria specified   Assay type/ Manufacturer                 Season Yr                   Predictors for low 25(OH)D                                                                                              25(OH)D Level Mean ng/ml % below cut-off
  ------------------ ------------------------------------- ------------------------------------ ---------------------------------------------- ------------------------------ ---------------------------------------- --------------------------- ----------------------------------------------------------------------------------------------------------------------- ------------------------------------------
  **Iran**           Ghergherechi et al. 2012[@R93]        Children hospital Tabriz (38°N)      52 Obese children\                             Yes                            CIA/ Nichols                             NA 2009--2011               Obesity, high BMI                                                                                                       Case: 32.7 ± 29.6\
                                                                                                4--16 y\                                                                                                                                                                                                                                                                   Control: 44.2 ± 11.2
                                                                                                57 Control                                                                                                                                                                                                                                                                 

                     Neysestani et al. 2012[@R86]          Random systematic\                   573 Boys, 538 Girls\                           Yes                            Competitive protein-binding assay/ IDS   Fall-winter\                Female gender                                                                                                           Boys: 11\
                                                           districts schools\                   9--12 y                                                                                                                2007--2008                                                                                                                                          Girls: 8
                                                           Tehran (35°N)                                                                                                                                                                                                                                                                                                   

                     Olang et al. 2011[@R87]               Vaccination heath centers\           7112 infants\                                  Yes                            HPLC                                     May-- June2001              Female gender                                                                                                           24.5\
                                                           Tehran (35°N)                        15-- 23 mo                                                                                                                                                                                                                                                                 3% \< 10 33% \< 20\
                                                                                                                                                                                                                                                                                                                                                                           44% 20--30 20% \> 30

                     Ardestani et al. 2010[@R91]           School random sampling\              271 Boys, 242 Girls 6--7 y                     Yes                            RIA/ Incstar                             Summer 2006                 Low intake of vitamin D, low sun exposure, dress style                                                                  46 ± 17\
                                                           Isfahan (32°N)                                                                                                                                                                                                                                                                                                  3% \< 20

                     Razzaghy Azar 2010[@R89]              Clinic university hospital\          192 Girls, 121 Boys 8--18 y                    Yes                            EIA/ IDS                                 Apr 2006-Apr 2007           High BMI, puberty stage, female gender                                                                                  25% (Boys 8% Girls 92%) \< 5\
                                                           Tehran (35°N)                                                                                                                                                                                                                                                                                                   27% (Boys 34% Girls 66%) 5--10\
                                                                                                                                                                                                                                                                                                                                                                           26% (Boys 58% Girls 42%) 10--20

                     Dahifar et al. 2007[@R30]             One middle school\                   414 Girls\                                     Yes                            Gamma counter/ Genesys                   Dec 2002- Mar 2003          NA                                                                                                                      30 ± 15.8
                                                           Tehran (35°N)                        11--15 y                                                                                                                                                                                                                                                                   

                     Moussavi et al. 2005[@R84]            High school Sampling\                153 Boys, 165 Girls 14--18 y                   Yes                            RIA/ Biosource                           NA 2004                     Female gender                                                                                                           Total: 46.2% \< 20\
                                                           Isfahan (32°N)                                                                                                                                                                                                                                                                                                  Boys: 37.3 ± 18.8\
                                                                                                                                                                                                                                                                                                                                                                           18% \< 20 1% \< 8\
                                                                                                                                                                                                                                                                                                                                                                           Girls: 16.8 ± 8.4\
                                                                                                                                                                                                                                                                                                                                                                           72% \< 20 14% \< 8

  **Jordan**         Abdul Razzak et al. 2011[@R88]        Hospital based\                      136 Infants,\                                  Yes                            EIA/ IDS                                 Oct 2008- Jan 2009          Sun exposure \< 30 min, female gender, exclusive breast feeding                                                         17% \< 15\
                                                           Amman (32°N)                         139 Toddlers\                                                                                                                                                                                                                                                              11% \< 20\
                                                                                                6--36 mo                                                                                                                                                                                                                                                                   28% \< 30\
                                                                                                                                                                                                                                                                                                                                                                           44% \> 30

                     Jazar et al.\                         Pediatrics Clinic Jordan (31°N)      100 Boys 1--3 y\                               Yes                            ECLIA/ Roche                             May -- June 2009            Older age, high BMI, low outdoor activity indoor physical activity, nutrition                                           Toddler: 26.2 ± 1.2\
                     2011[@R97]                                                                 100 Girls 3--6 y                                                                                                                                                                                                                                                           Preschool children: 21.5 ± 1.2\
                                                                                                                                                                                                                                                                                                                                                                           17% ≤ 15\
                                                                                                                                                                                                                                                                                                                                                                           16% 15- 20

                     Gharaibeh et al. 2009[@R98]           Local community center\              93 Mothers 30yrs Children 60.7 mo              Yes                            ELISA/IDS                                June -July 2007             Low milk intake,\                                                                                                       Mother: 10.2\
                                                           Jordan (31°N)                                                                                                                                                                           high income \> 212\$/month                                                                                              2% \< 5 49% \< 10 98% \< 20\
                                                                                                                                                                                                                                                                                                                                                                           Children: 22.3 82% \< 20 15% \> 30

  **Lebanon**        El Hajj-Fuleihan et al. 2007[@R99]    School based\                        180 Boys13.1 ± 2 y                             Yes                            RIA/ Diasorin                            Winter- Spring 2001--2002   NA                                                                                                                      17 ± 7
                                                           Beirut (33.5°N)                                                                                                                                                                                                                                                                                                 

                     El Hajj-Fuleihan et al. 2006[@R100]   School based\                        179 Girls 13.1 ± 2 y                           Yes                            RIA/ Diasorin                            Winter- Spring 2001--2002   NA                                                                                                                      14 ± 8
                                                           Beirut (33.5°N)                                                                                                                                                                                                                                                                                                 

                     El Hajj-Fuleihan et al. 2001[@R83]    School based\                        Spring:\                                       Yes                            RIA/ Diasorin                            Spring- Fall 1999           Spring season, female gender, age, Tanner staging, low sun exposure,\                                                   Spring:\
                                                           Beirut (33.5°N)                      81 Boys, 88 Girls 13.3 ± 1.6yrs\                                                                                                                   calcium intake, vitamin D intake, BMI                                                                                   Total:17 ± 8 21% \< 10 44% 10--20\
                                                                                                Fall:\                                                                                                                                                                                                                                                                     Boys:19 ± 7 9% \< 10 46% 10--20\
                                                                                                83 Boys, 94 Girls\                                                                                                                                                                                                                                                         Girls:15 ± 8 32% \< 10 42% 10--20\
                                                                                                13.3 ± 1.7yrs                                                                                                                                                                                                                                                              Fall:\
                                                                                                                                                                                                                                                                                                                                                                           Total: 22 ± 7 4% \< 10 36% 10--20\
                                                                                                                                                                                                                                                                                                                                                                           Boys: 24 ± 6.2 25% 10--20\
                                                                                                                                                                                                                                                                                                                                                                           Girls: 19 ± 7 7% \< 10 46% 10--20

  **Qatar**          Bener et al.\                         Primary Health Care Centers\         458\                                           No                             RIA/ Diasorin                            Aug 2007-Mar 2008.          Older Age, non White low sunlight expos, low physical activity, low dietary vit D, family history of vit D deficiency   69% \< 20 ng/ml, mean 13.4 ± 8.9\
                     2009[@R103]                           Doha (25.3°N)                        Mean 10.9 ± 3.54 y in those \< 20 ng/ml\                                                                                                                                                                                                                                   31% \< 20 ng/ml, mean 27.5 ± 8.3
                                                                                                Mean 9.54 ± 3.98 y in those 20--80 ng/ml                                                                                                                                                                                                                                   

  **Saudi Arabia**   Al-Ghamdi et al. 2012[@R85]           School-based\                        150 ♂ 7--16 y\                                 Yes                            ECLIA/ Roche                             May NA                      Female gender                                                                                                           16.5 ± 3.7 (6--9 y ♀)\
                                                           Jeddah (22°N)                        150 ♀ 6--18 y                                                                                                                                                                                                                                                              24.5 ± 5.2 (6--9 y ♂)\
                                                                                                                                                                                                                                                                                                                                                                           22 ± 4.5 (10--12 y ♂)\
                                                                                                                                                                                                                                                                                                                                                                           12.6 ± 3.7 (10--12 y ♀)\
                                                                                                                                                                                                                                                                                                                                                                           19.6 ± 5.2 (13--14 y ♂)\
                                                                                                                                                                                                                                                                                                                                                                           11.6 ± 3.6 (13--14 y ♀)\
                                                                                                                                                                                                                                                                                                                                                                           8.8 ± 3.8 (15--18 y ♀)\
                                                                                                                                                                                                                                                                                                                                                                           15.7 ± 5.6 (15--18 y ♂)

                     Al Othman et al. 2012[@R82]           Primary Health Care Centers\         331 (153♂178 ♀)\                               Yes                            ELISA /IDS                               Mar- Dec 2010               Low physical activity, low sun exposure                                                                                 7.1 ± 0.6 (Physically In Active)\
                                                           Riyadh (25°N)                        Physically inactive:\                                                                                                                                                                                                                                                      8.5 ± 0.6 (Moderate Activity)\
                                                                                                13.4 ± 3.2 y\                                                                                                                                                                                                                                                              9.1 ± 0.6 (Active)\
                                                                                                Moderate Activity:\                                                                                                                                                                                                                                                        11% \< 5 72% 5--10 17% 10--20
                                                                                                12.6 ± 3.3 y\                                                                                                                                                                                                                                                              
                                                                                                Active: 12.1 ± 3.6 y                                                                                                                                                                                                                                                       

                     Kensarah et al. 2012[@R102]           School-based\                        87 ♂ 61♀\                                      Yes                            ECLIA /Roche                             NA                          Female gender                                                                                                           97% ♀ \< 20\
                                                           Makkah (21°N)                        ♂10.4yrs,♀9.6yrs                                                                                                                                                                                                                                                           78% ♂ \< 20

  **UAE**            Rajah et al.\                         Pediatric outpatient clinics\        183 (52% ♂)\                                   Yes                            RIA /Diasorin                            All year 2005--2008         Sedentary lifestyle, veiling, Ca deficient diet.                                                                        Total:21.4 18% \> 10\
                     2012[@R101]                           Abu Dhabi(24°N)                      5.32 ± 3.76 y                                                                                                                                                                                                                                                              27.5 (0--0.9yrs) 31 (1--2yrs)\
                                                                                                                                                                                                                                                                                                                                                                           21.2 (2--8yrs) 14.1(8--12yrs)

                     Dawodu et al. 2003[@R90]              Maternal and child health clinics\   90 unsupp breast feeding Infants and Mothers   Yes                            HPLC                                     Apr- Oct 1999               Low dietary vit D intake, low sun exposure                                                                              Mothers 8.6 (61% \< 10)\
                                                           Al-Ain (24° N)                                                                                                                                                                                                                                                                                                  Infants 4.6 (82% \< 10)

                     Dawodu et al. 2001[@R104]             Hospital based\                      51\                                            Yes                            HPLC                                     Feb- Sep NA                 Low Vit D supplementation                                                                                               Infants 22% \< 10\
                                                           Al-Ain (24° N)                       15.4 mo\                                                                                                                                                                                                                                                                   25 ± 11.9 (dietary Vit D supp)\
                                                                                                UAE nationals (26) non-Gulf Arabs(25)                                                                                                                                                                                                                                      15.4 ± 10.9 (unsupp)\
                                                                                                                                                                                                                                                                                                                                                                           Mothers 50% \< 10\
                                                                                                                                                                                                                                                                                                                                                                           11.36 ± 5.6
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations in table listed here in alphabetical order. BMI: Body Mass Index; CIA: Chemiluminescent Assay; EIA: Enzyme immunoassay; ELISA: Enzyme-linked immunosorbent Assay; ECLIA: Electrochemiluminescent Immunoassay; HPLC: High-performance liquid chromatography; IDS: Immunodiagnostic Systems; NA: Not Available; RIA: Radioimmunoassay; Supp: Supplemented; Unsupp: Unsupplemented; Vit: Vitamin; Yrs: Years

###### **Table 3.** Overview of Studies on 25(OH) D Values in Pregnant Women/Neonates in Middle East

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country      Authors/Yr                   Sampling Method City (Latitude)                    N/ Age                                                     Exclusion criteria specified   Assay type/ Manufacturer            Season /Yr            Predictors for low 25(OH)D                     25(OH)D Level Mean ng/ml % below cut-off
  ------------ ---------------------------- -------------------------------------------------- ---------------------------------------------------------- ------------------------------ ----------------------------------- --------------------- ---------------------------------------------- ------------------------------------------
  **Iran**     Asemi et al. 2010[@R109]     Maternity clinic Kashan (34°N)                     147 pregnant ♀\                                            Yes                            HPLC                                NA/ 2008--2009        NA                                             15 ± 8
                                                                                               18--35 y                                                                                                                                                                                           

               Kazemi et al. 2009[@R108]    Maternity clinics general hospital Zanjan (37°N)   67 full-term pregnant mothers 28.5 ± 5 y and 61 neonates   Yes                            ELISA                               Mar- Sep 2005         Winter for maternal and cord blood             Mother 8 ± 1.5 Summer 13 Winter 3\
                                                                                                                                                                                                                                                                                                  Cord 7 ± 1 Summer 8.7 Winter 5

               Bassir et al. 2001[@R110]    Maternity Hospital Shohalda\                       50 mothers 16--40 y and their neonates                     Yes                            Radioligand assay                   Jan- Sep 1997         NA                                             Mother 5 ± 2 80% \< 10\
                                            Tehran (25--35°N)                                                                                                                                                                                                                                     Cord 2

  **Israel**   Mukamel et al. 2001[@R111]                                                      156 Orthodox and 185 non- Orthodox Jewish mothers\         Yes                            Competitive Protein Binding Assay   All year 1998--1999   Sect                                           Orthodox 13.5 ± 7.5\
                                                                                               at delivery                                                                                                                                                                                        5% \< 5 32% \< 10\
                                                                                                                                                                                                                                                                                                  Non-Orthodox 18.6 ± 9.6\
                                                                                                                                                                                                                                                                                                  3% \< 5 13% \< 10

  **Kuwait**   Molla et al. 2005[@R112]     Hospital based n = 2\                              214 pregnant mothers 27.7yrs\                              Yes                            RIA/ Incstar                        All year 1999--2000   NA                                             Mothers 13--17\
                                            Kuwait city (29 °N)                                and their neonates                                                                                                                                                                                 Neonates 8\
                                                                                                                                                                                                                                                                                                  40% mothers, 60% neonates \< 15

  **UAE**      Narchi et al. 2010[@R92]     Maternal and Child Health\                         75 pregnant from early pregnancy to 6 mo postpartum\       Yes                            RIA/IDS                             Sep-Nov 2007          Dietary habits,\                               First antenatal visit 17.3 ± 10.5\
                                            Al Ain (24°N)                                      18--40 y                                                                                                                                            voluntary avoidance of sun exposure, veiling   After delivery 14.4 ± 9.8\
                                                                                                                                                                                                                                                                                                  At 6 mo 11.9 ± 11.2
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations listed in alphabetical order: ELISA: Enzyme-linked immunosorbent Assay; HPLC: High-performance liquid chromatography; IDS: Immunodiagnostic Systems; NA: Not Available; RIA: Radioimmunoassay; Yrs: Years

Adults in Middle East
---------------------

### Iran

The mean 25(OH)D level in several cross-sectional studies of good to very good quality was in the low teens \[25(OH)D 10−15 ng/ml\],[@R39]^,^[@R40]^,^[@R42]^-^[@R45] and the majority of these studies used randomized cluster sampling that was population based, be it at city level or nation level.

### Jordan

Quite opposing results were found in two large, recent, population based studies graded as very good. The first included 4590 subjects and revealed a surprising high mean 25(OH)D level of 73 ng/ml in males and 40 ng/ml in females,[@R57] levels that remain unmatched in any other study or population. Conversely, a study of 2032 women, age 15−49 y revealed a median vitamin D of 11 ng/ml, 96% of subjects had levels below 20 ng/ml, and 60% were below a cut-off of 12 ng/ml.[@R56] While the former study used a Biosource assay, the latter used the gold standard LCMS assay to measure vitamin D. Aside from assay differences, reasons for such wide discrepancies remain unexplained.

### Lebanon

Several studies including a population-based study conducted in elderly subjects revealed mean 25(OH)D levels varying between the low-high teens \[25(OH)D 12--18 ng/ml\].[@R60]^,^[@R61]^,^[@R94]In an interesting sub-set analysis of a large international study in post-menopausal women, Lebanese Muslim women had lower levels than Christian women, findings that could in part be explained by dress style and higher BMI in Muslims.[@R60]

### Occupied Palestine/Israel

In general 25(OH)D mean levels were higher than those recorded in other countries in Middle East, including those reported in several large scale studies that took advantage of Health Maintenance Organization (HMO) or Non-Governmental Organization (NGO) databases, averaging around 20 ng/ml.[@R51]^,^[@R53]^,^[@R54] One ecological study revealed vitamin D levels to be highest in Ashkenazi Jews and lowest in Arabs.[@R55]

### Saudi Arabia

While several large sample population based studies as well as smaller studies revealed a high prevalence of hypovitaminosis D in Saudi Arabia (\> 80% below 20 ng/ml),[@R64]^,^[@R66]^,^[@R70] few smaller studies revealed replete levels.[@R72]^,^[@R74] In a sample of 1,172 women from of population-based survey of 40 primary health care centers around the city of Jeddah, 80% of subjects had a 25(OH)D level below 20 ng/ml. Mean levels in pre-menopausal women were 17 and in post menopausal women were 13 ng/ml.[@R67] Similarly a mean level of 12 ng/ml was found in a sample of 834 adults men, age 42 y.[@R64]

### United Arab Emirates

The mean levels from the three studies listed in [Table 1](#T1){ref-type="table"} are close to 10 ng/ml, with inverse seasonal pattern.[@R75]^-^[@R77]

Adults in North Africa
----------------------

Studies from this region are scarce, limited to Morocco and Tunisia. Two hospital-based studies conducted in women in Rabat revealed a 25(OH)D level in the mid-high teens.[@R78]^,^[@R79] Studies in Moroccan immigrants revealed similarly low levels.[@R95]^,^[@R96] A study of 100 immigrants with mean age of 49 y, showed a mean 25(OH)D of 11 ng/ml and 90% of subjects had mean levels below 20 ng/ml.^96^Findings were not different in Tunisian women, with mean levels again noted in mid-teens.[@R80]^,^[@R81]

Children and adolescents in the Middle East
-------------------------------------------

As detailed in [Table 2](#T2){ref-type="table"}[@R30]^,^[@R82]^-^[@R91]^,^[@R93]^,^[@R97]^-^[@R104] most studies reported mean 25(OH)D levels in teens or close to 20 ng/ml, thus again revealing a large proportion of apparently healthy children, that is 30--75%, to have 25(OH)D levels below this deemed desirable cut-off.

### Iran

Registered the largest number of studies with wide variations in 25(OH)D levels, in general being lower in winter, in girls and in older children. The proportion of subjects with 25(OH)D level below 20 ng/ml was 33% in 7,112 infants and toddlers in Tehran (36° North) in early summer,[@R87] 3% in a sample of 513 young school children, age 6−7 y in Isfahan (33° North) in the summer,[@R91] up to 78% in school adolescents from Tehran in the spring,[@R89] and 46% in high school students.[@R84] Mean levels were quite low in the winter in 1,111 older school children from Tehran, measured at 11ng/ml in boys and 8 ng/ml in girls,[@R86] and surprisingly high in middle school girls in Isfahan in winter.[@R30]

### Jordan

Two studies conducted in hospital based clinics in Amman, in toddlers and pre-school children, one in summer and the other in the winter, revealed that one-third of subjects had mean 25(OH)D levels below 20 ng/ml,[@R88]^,^[@R97] while a community based sample in 93 children mean age 60 mo, in the summer of 2007, revealed the proportion to be even higher at 82%.[@R98]

### Lebanon

Two separate studies reported mean 25(OH)D levels in mid-teens conducted in school adolescents from greater Beirut.[@R83]^,^[@R99]^,^[@R100] Between 30--40% had a mean 25(OH)D levels below 20 ng/ml, proportions being higher in the winter and in girls.

### Saudi Arabia

A school-based study reveals 25(OH)D levels in mid-high teens in children, being lower in girls than boys, whereas mean levels were below 10 ng/ml in a study of adolescents recruited from primary health care centers in Ryadh.[@R82]^,^[@R85]

### United Arab Emirates

In study of 183 children, age 1−12 y, selected from an urban ambulatory clinic in Abu Dhabi, there was a decrease in 25(OH)D levels with age from infancy to early adolescence; 21% of girls and 16% of boys had a 25(OH)D below 10 ng/ml, and the proportions were 46% and 32% respectively for a cut-off below 20 ng/ml.[@R101] Levels were lower in mother and infants from 2 hospital based studies, where 61% of the mothers and 82% of the 78 infants tested had hypovitaminosis D (serum 25(OH)D \< 10 ng/ml).[@R90]^,^[@R104]

### Qatar

In a small study of 65 school girls, age 9−15 y, 25(OH)D levels were below 20 ng/ml in 98%.[@R105] The weighted average for 25(OH)D was 17.5 ng/ml level in 458 subjects, age \< 16 y, attending a primary health clinic and was less than 20 ng/ml in 69%.[@R103]

We could not identify any studies conducted in children and adolescents for countries in North Africa.

Pregnant women and neonates
---------------------------

A systematic review of first trimester normative 25(OH)D levels, of 18 studies across the world, revealed mean 25(OH)D levels ranging between 29 and 73 nmol/L in white Caucasian women and between 15--26 nmol/L in Turkish and Moroccan and other non-western women in Netherlands.[@R106] Similarly, a high prevalence of low 25(OH)D levels was reported in ethnic minority groups in western countries, the prevalence ranged between 59--84% in the Netherlands, exceeded 50% in the UK, averaged 61% in New Zealand, was above 80% in Australia, using a cut-off of 10 ng/ml; and it was 5--30% in the US at a cut-off of 15 ng/ml.[@R7] Investigations in Saudi Arabia, Kuwait, United Arab Emirates and Iran reveal that 10--60% of mothers and 40--80% of their neonates had undetectable low 25(OH)D levels (0--25 nmol/L) at delivery.[@R106] Such low levels may be associated with poor maternal and neonatal outcomes, as has been documented in women from western countries. Indeed, Caucasian women with low 25(OH)D levels had a higher risk of pre-eclampsia and Cesarean sections, but we are unaware of any such studies in the ME or Asia.[@R106] More recently, children of women with low 25(OH)D levels in third term had smaller anthropometric parameters.[@R107] In Iran, neonates born to mothers with low 25(OH)D levels have lower cord 25(OH)D levels, and in one study were more likely to have lower birth weight, height, Apgar score and may be at risk for the development of rickets.[@R106] Unfortunately, the few studies conducted in the MENA were not population-based and thus not necessarily representative of vitamin D nutritional status of pregnant women and their neonates in the region. But the few studies available, revealed a 25(OH)D level below 20 ng/ml in mothers in all 6 studies and below 10 ng/ml in two of them and even lower levels in neonates and cord blood.[@R108]^-^[@R112] Predictors for low maternal 25(OH)D levels included dress code, winter season, dietary habits and avoidance of sun exposure.[@R92]^,^[@R108]

Is There a Genetic Basis for Low Vitamin D Levels and Rickets in the MENA?
==========================================================================

Lifestyle factors, namely sunlight exposure, diet and use of supplements, are well recognized major determinants of circulating 25(OH)D levels, in general,[@R1] including subjects from the MENA, as detailed above. Interestingly, it has been recently underscored that genetic factors may contribute up to 50% of inter-individual variability in serum 25(OH)D levels ([Fig. 1](#F1){ref-type="fig"}).[@R113] Several genetics determinants of vitamin D status were recently described in a large genome wide association study of over 30,000 individuals of European descent from 15 cohorts.[@R114] In addition, single nucleotide polymorphisms (SNPs) at or near 6 pre-specified vitamin D pathways candidate genes were considered. These include the vitamin D receptor (VDR), 1-α-hydroxylase *(CYP27B1)*, 25-hydroxylase *(CYP2R1),* 24-hydroxylase *(CYP24A1),* vitamin D binding protein *(GC, DBP)* and 27- and 25-hydroxylse *(CYP27A1)* genes. The discovered genetic polymorphisms included variants near genes involved in cholesterol synthesis (*DHCR7)*, hydroxylation *(CYP2R1* and *CYP24A1)* and vitamin D transport *(GC)*, and these may identify individuals at high risk of vitamin D deficiency.[@R114] African Americans are a subgroup at higher risk for low vitamin D levels. A recent study investigating associations between 94 three single nucleotide polymorphisms (SNPs) in 5 vitamin D pathway genes (GC, VDR, CYP2R1, CYP24A1, CYP27B1) and serum 25(OH)D in 379 African American and 379 Caucasian controls, revealed statistical associations for 3 SNPS, 2 in the vitamin D transport pathway and one in the hydroxylation pathway, only in African Americans.[@R115] Loss of CYP2R1 was also shown to be associated with 25(OH)D deficiency in several families in Nigeria[@R116]^-^[@R118] and associations between VDR polymorphisms and rickets in subjects from the Middle East has also been previously raised.[@R31]^,^[@R119] In a retrospective study of 34 Saudi children above age 10 y, who presented with rickets to a major hospital in Riyadh between 1994--2000, 59% had vitamin D deficiency, 11% calcium deficiency, 3% renal failure and 27% genetic causes. Of the total, 12% were reported by authors to have hypophosphatemic rickets, 9% to have 25-hydroxylase deficiency and 6% to suffer from vitamin D dependent rickets type I.[@R119] In addition, a recent report of 2 adolescent siblings from a Saudi family presenting with short stature and rickets, revealed 2 new mutations in CYP2R1.[@R120] The classical biochemical profile of very low 25(OH)D levels (below 4 ng/ml), within normal range calcitriol levels, the very high doses needed to normalize serum 25(OH)D levels, and an autosomal recessive inheritance pattern, had raised the author\'s suspicion for 25 hydroxylase deficiency. Residual hydroxylase function in the mutant allele or the presence of other hydroxylase enzymes that became more functional, in the presence of high levels of substrate, were proposed as possible mechanisms for the correction with supra-physiologic doses of vitamin D.[@R120]

![**Figure 1.** Serum 25(OH)D Levels in Adults **(A)** and Children **(B)** Based on Color Codes. The color codes are: green \> 30 ng/ml, yellow 20--29 ng/ml, orange 10--19 ng/ml, and red \< 10 ng/ml. To convert from ng/ml to nmol multiply by 2.5. The color codes were selected based on mean or median results from population based studies available or as obtained from most representative studies for each country. For countries with varying results, the color code was chosen as valid for ≥ 50% of reported values; or more than one color code was used (for, e.g., children in Iran).](de-5-274-g1){#F1}

In conclusion, there is a growing body of substantial evidence supporting a genetic basis for low 25(OH)D levels in several populations and some data for it in cases of rickets in the MENA, the latter is however based on small series and case reports. Thus the need for large scale population based genome wide association studies to adequately address this question in a definitive manner.

Impact of Vitamin D on Surrogate Markers or Major Health Outcomes in MENA
=========================================================================

The evidence for a beneficial effect of vitamin D on musculoskeletal health and a potential effect on non-classical outcomes, such as cardiovascular diseases, diabetes, inflammatory, infectious, immune disorders and cancers, as well as mortality has been extensively reviewed,[@R1]^,^[@R3]^,^[@R5]^,^[@R121]^,^[@R122] and is beyond the scope of this paper. Cardiovascular diseases, maternal-neonatal health and infections are on the top of the health agenda of the World Health Organization and health authorities in countries worldwide, including the MENA region. Association and intervention studies evaluating the relationship between vitamin D and health outcomes, available to-date in the MENA region, will be examined here-in [Table 4](#T4){ref-type="table"},[@R61]^,^[@R94]^,^[@R123]^-^[@R140] and [Table 5](#T5){ref-type="table"}.[@R100]^,^[@R141]^-^[@R149]

###### **Table 4.** Overview on Association Studies Between 25(OH) D Levels and Health Outcomes in the Middle East and North Africa

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country                          Author/Yr                         Sampling Method City\                                                Assay type /Manufacturer   Exclusion criteria specified   Disease condition\            25(OH)D Level\                   Association between 25(OH)D and outcome (Correlation)
                                                                     Cases/ Controls N Gender/ Age                                                                                                  /Health Outcomes              Mean ng/ml                       
  -------------------------------- --------------------------------- -------------------------------------------------------------------- -------------------------- ------------------------------ ----------------------------- -------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------
  **Egypt**                        Olama et al.\                     Clinic based\                                                        ELISA/IDS                  Yes                            Fibromyalgia                  Cases: 15.1 ± 6.1\               Lumbar spine: r = -0.352\
                                   2012[@R123]                       Cases: 50 ♀ 32.3 ± 9.4 y\                                                                                                                                    Controls: 18.8 ± 5.4             VAS of pain: r = -0.338\
                                                                     Controls: 50 healthy ♀ 33.1 ± 9.7 y                                                                                                                                                           Beck score for depression: r = -0.328

                                   El Husseiny et al. 2012[@R124]    Clinic based Cairo\                                                  RIA/Incstar                Yes                            HCV infection                 Cases: 15 ± 5.2\                 Cases:\
                                                                     Cases: 36♂, 14 ♀ 30--65 y\                                                                                                                                   Controls: 39.7 ± 10.8            Viral load: r = -0.84 IL-23: r = -0.776\
                                                                     Controls:: 25 age- and gender-matched healthy subjects                                                                                                                                        IL-17: r = -0.665 MCP-1: r = -0.94

                                   Schaalan et al. 2012[@R125]       Clinic based Cairo\                                                  RIA/Incstar                Yes                            HCV infection                 Cases: ♂10.30 ± 2.12\            Cases:\
                                                                     Cases: 36♂, 14 ♀\                                                                                                                                            ♀10.00 ± 2.60\                   25(OH)D and IL-17: r = -0.679\
                                                                     Controls:: 25 age- and gender matched healthy subjects                                                                                                       Controls: 39.70 ± 10.80          1.25(OH)D and IL-17: r = -0.679\
                                                                                                                                                                                                                                                                   1.25(OH)D and IL-23: r = -0.801

                                   Hamza et al.\                     Clinic, Hospital and university based Cairo\                         ELISA/ VDBP                Yes                            SLE                           Cases: 26.33 ± 12.05\            SLEDAI: r = -0.91
                                   2011[@R126]                       Cases: 52 ♀ and 8 ♂/ 6--19 y\                                                                                                                                13% \< 10 60% \< 30 27% \> 30\   
                                                                     Controls: 50 ♀, 10 ♂/ 7.2--18.5 y                                                                                                                            Controls: 42.66 ± 9.20           

                                   Al Sayed\                         Clinic based Cairo\                                                  RIA/IDS                    Yes                            Metabolic syndrome            Cases: 16.2 ± 4.52\              Cases:\
                                   2007[@R127]                       Cases:93♂♀ 45.2 ± 2.6 y\                                                                                                                                     Control: 25 ± 4.48               BMI: r = -0.684 HOMA: r = -0.395\
                                                                     Controls:70 healthy 47.1 ± 3.1 y                                                                                                                                                              HDL: r = 0.277 PTH: r = -0.235\
                                                                                                                                                                                                                                                                   S. Insulin:r = -0.396

  **Iran**                         Khalili et al.\                   Hospital based Tehran\                                               RIA/ Abcam pic             Yes                            Acute Myocardial infarction   10.92 ± 7.2                      Hypertension: OR = 2.92\
                                   2012[@R128]                       139 ♀ \> 55 y, ♂ \> 45 y                                                                                                                                                                      Use of cardiovascular drugs: OR = 2.36\
                                                                                                                                                                                                                                                                   Survival: OR = 0.216

                                   Hosseinpanah et al. 2011[@R129]   Population based Tehran\                                             EIA/ DRG                   Yes                            Cardiovascular                Median\                          Vit D \< 10 had an almost 3-fold higher risk of developing cardiovascular outcomes r^a^ = 2.90 than those between 10--15ng/ml r = 1.46
                                                                     Cases: 251♂♀ 56.0 ± 10.6 y\                                                                                                                                  Cases: 12.5 (8.4--24.4)\         
                                                                     Controls: 251 healthy subjects 56.7 ± 11.7 y                                                                                                                 Controls: 18.1 (11--31)          

                                   Bonakdar et al. 2011[@R130]       Clinic based Isfahan\                                                RIA/ DIAsource             Yes                            SLE                           9.68 ± 0.84                      BILAG: r = -0.486\
                                                                     40 ♀ 25.46 ± 4.16 y                                                                                                                                                                           BILAG after Adjustment: r^b^ = - 0.292\
                                                                                                                                                                                                                                                                   Low vit D higher titers of anti-dsDNA

                                   Heidari et al. 2010[@R131]        Clinic based Babol\                                                  ELISA/DRG                  Yes                            Musculoskeletal pain          Cases: 33.1 ± 28.4\              Vit D \< 20 vs. ≥ 20 with:\
                                                                     Cases: 276 ♂♀ 44.3 ± 15 y\                                                                                                                                   Controls: 23.8 ± 29.1            Musculoskeletal pain: OR^c^ = 2.95\
                                                                     Controls: 202♂♀ 46.4 ± 14.2 y                                                                                                                                                                 Leg pain: OR^c^ = 7.4\
                                                                                                                                                                                                                                                                   Widespread pain: OR^c^ = 2.8\
                                                                                                                                                                                                                                                                   Arthralgia: OR^c^ = 3.9

                                   Garakyaraghi et al. 2010[@R132]   Hospital based Isfahan\                                              CIA/Diasorin               Yes                            Heart failure                 56.78 ± 51.33                    Diastolic volume: r = −0.24\
                                                                     28 ♀, 67 ♂ 62 ± 11 y                                                                                                                                                                          Adjusted for age, Creatinine: r = −0.261

                                   Bonakkdaran et al. 2009[@R133]    Hospital based Mashhad\                                              RIA/Biosource              Yes                            T2DM                          32.4 ± 21.6                      Age: r = -0.21, BMI: r = -0.25, CRP: r = -0.06
                                                                     119 ♂♀ 55.3 ± 11.2 y                                                                                                                                                                          

                                   Omrani et al. 2006[@R134]         Cluster sampling Shiraz\                                             IRMA/ IDS                  Yes                            Mineral Metabolism            28.9 ± 23.0                      PTH r = --0.10\
                                                                     676 healthy women aged 20--74 y                                                                                                                                                               Independent of age

  **Occupied Palestine/ Israel**   Saliba et al.\                    Population Based Clalit Health Services\                             CIA/DiaSorin               Yes                            Primary Hyperparathyroidism   Cases: 19 ± 9\                   Cases:\
                                   2012[@R135]                       Cases: 1180 ♂♀ 65.30 ± 13.52 y\                                                                                                                              Controls: 20.8 ± 9.8             PTH: r = −0.238 ALKPhos: r = −0.180 Calcium: r = −0.054
                                                                     Controls:184,479 ♂♀ 57.67 ± 18.25 y                                                                                                                                                           

                                   Amital et al. 2010[@R136]         278 with systemic lupus erythematosus activity (SLEDAI)\             CIA/Diasorin               No                             SLE                           SLEDAI: 23.9 ± 14.0\             Standardized values z-scores r = -0.12 The more active the disease, the lower the vitamin D concentration
                                                                     100 with European Lupus activity measurement (ECLAM) 40.2 ± 14.2 y                                                                                           ECLAM: 27.6 ± 13.9               

  **Lebanon**                      Arabi et al.\                     Population based Beirut\                                             RIA/ IDS                   Yes                            BMD\                          ♂ 14.7 ± 4.0\                    Overall:\
                                   2012[@R94]                        65 ♂and 130 ♀ 72.5 ± 5.1 y                                                                                                     Mineral Metabolism            ♀ 14.6 ± 7.4                     % Change Trochanter BMD: r^d^ = 0.19\
                                                                                                                                                                                                                                                                   ♂:% Change Total hip BMD: r^d^ = 0.31\
                                                                                                                                                                                                                                                                   % Change F. Neck BMD: r^d^ = 0.36\
                                                                                                                                                                                                                                                                   % Change Trochanter BMD r^d^ = 0.26

                                   Arabi et al.\                     Population based Beirut\                                             RIA/ IDS                   Yes                            BMD\                                                           ♀BMD Total hip, FN, Troch: r^e^ = 0.10--0.18\
                                   2006[@R61]                        286♀ 73.4 ± 5.2 y\                                                                                                             Mineral Metabolism                                             ♂ BMD Total hip,spine, FN, Troch:r^e^ = 0.16 -0.27
                                                                     157♂ 74.1 ± 5.08 y                                                                                                                                                                            

  **Qatar**                        Bener et al.\                     Clinics /Face to face Interviews Doha\                               RIA/DiaSorin               No                             T1DM                          Cases: 15.8 ± 9.2\               NA
                                   2009[@R137]                       Cases: 170 ♂♀ 10.5 ± 3.8 y\                                                                                                                                  Controls:18.5 ± 9.6              
                                                                     Controls: 170 ♂♀ 9.9 ± 4.2. yrs                                                                                                                                                               

  **Saudi Arabia**                 Bin --Abbas et al. 2011[@R138]    Pediatric and Endo Clinics Riyadh\                                   HPLC                       Yes                            T1DM                          Cases: 14.7 ± 5.7\               No Correlation between glycemic control and 25 OHD level.
                                                                     Cases:59 ♀ 41 ♂\                                                                                                                                             Controls:17.9 ± 5.6              
                                                                     Controls: 52♀ 48 ♂                                                                                                                                                                            

                                   Al Daghri et al. 2010[@R139]      Primary Health Care Centers Riyadh\                                  ELISA/ IDS                 Yes                            T2DM                          Cases: 10.8 ± 4.7\               Cases: TC: r = -0.20 LDL-C: r = -0.17\
                                                                     Cases: 76 ♀, 88 ♂ 50.6 ± 10.1 y\                                                                                                                             Controls: 7.2 ± 2.9              TG: r = -0.17 BMI: r = -0.22\
                                                                     Controls: 106 ♀, 71 ♂non-diabetic\                                                                                                                                                            Controls: SBP: r = 0.22 WHR: r = 0.16\
                                                                     37.5 ± 15.3 y                                                                                                                                                                                 Non-Adjusted values

  **Yemen**                        Salem et al.\                     Hospital based Sana'a\                                               ELISA/ IDS                 yes                            Very severe pneumonia,\       Deficient n = 50:37.2 ± 17.3\    Failure to respond to antibiotic therapy in rachitic compared with non rachitic OR = 1.38
                                   2009[@R140]                       152 children with VSP 2--59 mo                                                                                                 some with rickets             Sufficient n = 9: 47.3 ± 17.6    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Only significantly different 25(OH)D levels between cases and controls, and correlations .Details on studies that presented adjusted correlations are as follows: Hosseinpahanh et al. 2011, r^a^ adjusted for BMI, FPG, SBP, DBP,CT,TG,HDL-C, Smoking Status, degree of physical activity, premature CVD familial history . Bonakdar et al. 2011, r^b^ adjusted for age, BMI, sun exposure, use of sunscreen, physical activity. Heidari et al. 2011, OR^c^ adjusted for sex. Arabi et al. 2012, r^c^ adjusted for age, calcium intake, serum Creatinine and PTH in multivariate models, mean 25OHD was no more a predictor of bone loss. Arabi et al. 2006, r^d^ adjusted for age, height, lean mass and PTH levels, 25OHD level did not have residual significant contribution to BMD at any skeletal site except the trochanter in men. Abbreviations in table listed here in alphabetical order: ALKPhos:Alkaline Phosphatase; BILAG: British Isles Lupus Assessment Group; BMD: Bone Mineral Density; BMI: Body Mass Index; CIA: Chemiluminescent Assay; CRP: C- Reactive Protein; DsDNA: Double Stranded DNA; EIA: Enzyme immunoassay; ELISA: Enzyme-linked immunosorbent Assay; ECLAM: European Consensus Lupus Activity Measurement; FN: Femoral Neck; HCV: Hepatitis C virus; HDL: High Density Lipoprotein; HOMA: Homeostasis Model Assessment ; HPLC: High-performance liquid chromatography; IDS: Immunodiagnostic Systems; IL-17: Interleukin-17; IL-23: Interleukin-23; IRMA: Immunoradiometric Assay; LDL-C: Low Density Lipoprotein- Cholesterol; MCP-1: Macrophage chemoattractant protein-1; NA: Not Available; OR: Odds Ratio; r: Correlation; RIA: Radioimmunoassay; SBP: Systolic Blood Pressure; SLE: Systemic Lupus Erythematosus; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; TC: Total Cholesterol; TG: Triglycerides ; Troch: Trochanter; T1DM: Type 1 Diabetes Mellitus; T2DM: Type 2 Diabetes Mellitus; Vit: Vitamin; VAS: Visual Analogue Scale; VSP: Very Severe Pneumonia; VDBP: Vitamin Tracer, for the Binding Pocket of Vitamin D Protein; WHR: Waist Hip Ratio; Yrs: Years

###### **Table 5.** Overview on Interventional Studies between 25(OH)D Levels and Health Outcomes in the Middle East

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country            Author\                      Sampling Method\                               Protocol Design                     Intervention\                                                                      Assay type/ Manufacturer       Exclusion criteria specified       25(OH)D Level Mean ng/ml                                      Effect on Health Outcome
                     Yr                           City (Latitude)\                                                                   Type/Dose/Duration                                                                                                                                                                                                 
                                                  N Gender/ Age                                                                                                                                                                                                                                                                                         
  ------------------ ---------------------------- ---------------------------------------------- ----------------------------------- ---------------------------------------------------------------------------------- ------------------------------ ---------------------------------- ------------------------------------------------------------- ------------------------------------------------------------------------------
  **Iran**           Shakinba et al.\             School Based\                                  RCT                                 Group 1: 300,000 IU D3 once,\                                                      CIA/DiaSorin                   No                                 Baseline One year\                                            NA
                     2011[@R141]                  Yazd (32°N)\                                                                       randomized to 50,000IU D3/month\                                                                                                                     Group 1 29.7 ± 4.6 47% 20--30\                                
                                                  120 girls 12--15 y\                                                                Group 2: 300,000 IU D3 once,\                                                                                                                        53% 30--100\                                                  
                                                  Group 1: 28 with Vit D Deficiency\                                                 randomized to 100,000 IU D3/\                                                                                                                        Group 2 30 ± 5.6 57% 20--30\                                  
                                                  Group 2: 23 with Vit D Deficiency\                                                 3 mo\                                                                                                                                                43% 30--100\                                                  
                                                  Group 3: 30\                                                                       Group 3: 50,000 IU D3/3 mo\                                                                                                                          Group 3 15.2 ± 6 13% \< 10\                                   
                                                  Group 4: 30                                                                        Group 4: 100,000 IU D3/3 mo                                                                                                                          73% 10--20\                                                   
                                                                                                                                                                                                                                                                                          11% 20--30\                                                   
                                                                                                                                                                                                                                                                                          3% 30--100\                                                   
                                                                                                                                                                                                                                                                                          Group 4 23 ± 6.8 45% 10--20\                                  
                                                                                                                                                                                                                                                                                          35% 20--30\                                                   
                                                                                                                                                                                                                                                                                          19% 30--100                                                   

                     Ghazi et al.\                School Based\                                  Double-blinded RCT                  Group A:50,000 IU D3/monthly\                                                      ELISA/IDS                                                         Baseline 6 mo\                                                NA
                     2010[@R142]                  Tehran (35.7°N)\                                                                   Group B: 50,000 IU D3/2 mo+ placebo every alternative month\                                                                                         Group A: 12.8 ± 8.8 ♀19.2 ± 9.4\                              
                                                  105 ♂, 105 ♀14--20 y 16 ± 1.5 y\                                                   Group C:Placebo                                                                                                                                      ♂29 ± 10.5\                                                   
                                                  Group A:35♂,35♀\                                                                                                                                                                                                                        Group B: 11.3 ± 5.8 ♀13.5 ± 9.2\                              
                                                  Group B:34♂,35♀\                                                                                                                                                                                                                        ♂23.1 ± 7.6\                                                  
                                                  Group C:34♂,35♀                                                                                                                                                                                                                         Group C: 11.6 ± 7.2 ♀8 ± 5.6\                                 
                                                                                                                                                                                                                                                                                          ♂15.6 ± 6.4                                                   

  **Israel**         Gotsman et al.\              Population based Clalit Health Services\       A-Case-Control\                     B. 800 IU/d and 1000 IU/d for median follow up of 518 d.                           RIA/DiaSorin                   No                                 A- Cases Median:14.8\                                         Reduced Mortality in Heart Failure patients HR = 1.52 and controls HR = 1.91
                     2012[@R143]                  A- 3009 ♂♀ with Heart Failure 75.9 ± 10.7 y\   B-Interventional                                                                                                                                                                         Controls Median:16.3\                                         
                                                  46,825♀♂ controls 64.7 ± 11.3 y\                                                                                                                                                                                                        B- Survival Rate\                                             
                                                  B- 791 ♂♀with Heart Failure\                                                                                                                                                                                                            HF patients \< 10 ng/ml with supplementation:85.6 ± 1.7%\     
                                                  458 ♂♀ with supplementation\                                                                                                                                                                                                            HF patients \< 10 ng/ml without supplementation:81.6 ± 1.7%   
                                                  333 ♀♂without supplementation                                                                                                                                                                                                                                                                         

  **Lebanon**        El-Hajj Fuleihan\            School Based\                                  Double-blinded RCT                  Group A:Placebo\                                                                   RIA/DiaSorin                   Yes                                Baseline One year\                                            Low dose and High dose: increase in BMD, Lean Mass\
                     et al 2006[@R100]            Beirut (33°N)\                                                                     Group B: Low dose 200 IU D3/d\                                                                                                                       Group A: 14 ± 7 16 ± 8\                                       High dose:increase in Total BMD, Bone Area\
                                                  179 ♀\                                                                             Group C: High dose 2000 IU D3/d                                                                                                                      Group B: 14 ± 9 17 ± 6\                                       Premenarcheal girls had the highest increment
                                                  Group A: 13 ± 2.1 y\                                                                                                                                                                                                                    Group C: 14 ± 8 38 ± 31                                       
                                                  Group B: 13.1 ± 2.2 y\                                                                                                                                                                                                                                                                                
                                                  Group C: 13.6 ± 2.1 y                                                                                                                                                                                                                                                                                 

  **Country**        **Author**\                  **Sampling Method**\                           **Protocol Design**                 **Intervention**\                                                                  **Assay type/ Manufacturer**   **Exclusion criteria specified**   **25(OH)D Level Mean ng/ml**                                  **Effect on Health Outcome**
                     **Yr**                       **City (Latitude)**\                                                               **Type/Dose/Duration**                                                                                                                                                                                             
                                                  **N Gender/ Age**                                                                                                                                                                                                                                                                                     

  **Qatar**          Soliman et al. 2011[@R144]   General Practitioner Clinic\                   Prospective\                        600,000 IU D3 every 2--3 mo                                                        RIA                            No                                 Pre-Interv Post Interv\                                       Healing of Rickets in all patients at one year.
                                                  Doha(25.3°N)\                                  Open-Label\                                                                                                                                                                              9.3 ± 4.6 27.7 ± 9.2                                          
                                                  40 Adolescents with Vit D Deficiency           Non-Randomized                                                                                                                                                                                                                                         

  **Saudi Arabia**   Al-Daghri et al.\            Primary Health Care Centers\                   Interventional                      Advice for 5--30 min sun exposure twice/ week and vitamin-D rich foods             ELISA/IDS                      Yes                                Baseline 6 mo 12 mo\                                          Decrease of Metabolic Syndrome from 25% to 13%
                     2012[@R145]                  Riyadh (24.6°N)\                                                                                                                                                                                                                        7.6 ± 0.6 10.7 ± 0.6 11.4 ± 0.6                               
                                                  31♂28♀ 18--65 y 38 ± 14.1 y                                                                                                                                                                                                                                                                           

  **UAE**            Rajah et al.\                Hospital Based\                                Retrospective\                      Group 1:2000 IU D2/d for 3 mo +400 IU D2/d subsequently+ Ca 40 mg/Kg/d for 3 mo\   HPLC                           Yes                                Baseline 3 mo\                                                NA
                     2010[@R146]                  Abu Dhabi (24°N)\                              Audit                               Group 2: stosstherapy 600,000IU D2 single dose + Ca 40 mg/Kg/d for 3 mo                                                                              15.1 ± 10.3 NA\                                               
                                                  10 Children with Rickets:\                                                                                                                                                                                                              Median: 11.6 Median: 57.4                                     
                                                  Group 1: 7 children\                                                                                                                                                                                                                                                                                  
                                                  Group 2: 3 children\                                                                                                                                                                                                                                                                                  
                                                  21.2 ± 8.4 mo                                                                                                                                                                                                                                                                                         

                     Saadi et al.\                Maternal-Child Health Clinic\                  RCT                                 Mothers:\                                                                          RIA /DiaSorin                  No                                 Mothers Pre-Interv Post Interv\                               NA
                     2009[@R147]                  Al-Ain(24°N)\                                                                      Group 1:2000 IU D2/d for 3 mo\                                                                                                                       Group 1: 11 ± 4 16.9 ± 5.6\                                   
                                                  Group 1: 22 mothers 28.1 ± 4.7 y\                                                  Group 2:60,000 IU D2/m for 3months\                                                                                                                  Group 2: 8.9 ± 4 15 ± 4\                                      
                                                  Group 2: 22 mothers 27.6 ± 6.5 y\                                                  Infants:400 IU D2/d for 3 mo                                                                                                                         Infants 30% \< 20 ng/ml at 3 mo\                              
                                                  Group 1: 22 infants 19.1 ± 25.4 d\                                                                                                                                                                                                      Group 1: 5.6 ± 3.4 19.8 ± 7.4\                                
                                                  Group 2: 24 infants 20.6 ± 22.9 d                                                                                                                                                                                                       Group 2: 5.5 ± 4.8 17.8 ± 6                                   

                     Rajah et al.\                Hospital Based\                                Quasi-Experimental Non-Randomized   2000--5000 IU D2/d for 3 mo + 400 IU D2/d for a variable period                    CIA/Nichols                    No                                 Baseline:\                                                    Height z-score\
                     2008[@R148]                  Abu Dhabi (24°N)\                                                                                                                                                                                                                       8 Vit D deficient: 6.9 ± 1.3\                                 Entry: -1.74 Termination:-0.88
                                                  31 Children with Rickets:\                                                                                                                                                                                                              8 Ca deficient: 17.7 ± 7.1                                    
                                                  8 Vit D deficient 14.8 ± 3.2 mo\                                                                                                                                                                                                                                                                      
                                                  8 Ca deficient 19.8 ± 2.3 mo                                                                                                                                                                                                                                                                          

                     Saadi et al.\                Maternal-Child Health Clinic\                  Open-Label\                         Group 1:2000 IU D2/d for 3 mo\                                                     RIA /DiaSorin                  Yes                                Lactating Pre-Interv Post-Interv\                             1/3 ♀achieved 25(0H)D ≥ 20ng/ml
                     2007[@R149]                  Al-Ain(24°N)\                                  RCT                                 Group 2:60,000 IU D2/m for 3months                                                                                                                   Group 1: 10.9 ± 4.2 17 ± 5.6\                                 
                                                  Group 1:45 lactating♀29.2 ± 5.5yrs\                                                                                                                                                                                                     Group 2: 9.3 ± 4.3 15 ± 4.2\                                  
                                                  Group 2:45 lactating♀29.9 ± 6.7yrs\                                                                                                                                                                                                     Nulliparous\                                                  
                                                  Group1:43nulliparous♀23 ± 5.2yrs\                                                                                                                                                                                                       Group 1: 7.8 ± 5 16.7 ± 10.6\                                 
                                                  Group2:45nulliparous♀24.6 ± 5.1yrs                                                                                                                                                                                                      Group 2: 7.6 ± 4.9 15.7 ± 8.6                                 
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations in table listed here in alphabetical order: BMD: Bone Mineral Density; Ca: Calcium; CIA: Chemiluminescent Assay; ELISA: Enzyme-linked immunosorbent Assay; HPLC: High-performance liquid chromatography; HR: Hazard Ratio; IDS: Immunodiagnostic Systems; NA: Not Available; RIA: Radioimmunoassay.

Associations studies
--------------------

### Musculoskeletal health

Significant negative associations between 25(OH)D and PTH levels were reported in young and old Lebanese subjects,[@R62] adults and elderly subjects from Iran,[@R134]^,^[@R150] and patients with hyperparathyroidism from Israel.[@R135] Positive associations between 25(OH)D levels and bone mass were also reported at several skeletal sites, in adolescent Lebanese girls[@R100] and elderly subjects.[@R61] In the elderly Lebanese, 25(OH)D levels also correlated with lean mass in men but not women and the correlations with BMD disappeared for all skeletal sites except for trochanter after adjusting for lean mass and PTH.[@R61] In the same study, subjects were followed prospectively and25(OH)D levels significantly correlated with bone loss over a mean follow-up of 4.4 y. This relation disappeared after adjusting for PTH levels.[@R94] In the adolescent study, there were no significant relationships between VDR genotype and baseline bone mass BMD, but in the elderly study, elderly women with the heterozygous VDR genotype had the highest bone mass at the lumbar spine and forearm.[@R151]

### Non-classical outcomes

Lower mean 25(OH)D levels were reported in patients with type I DM in Saudi Arabia and Qatar[@R137]^,^[@R138] and it has been suggested that low levels may also contribute to metabolic syndrome and type II DM.[@R152] This is particularly pertinent, considering that the Middle East registers some of the highest rates for obesity, exceeding the rising tide in western countries, reaching 40--50%,[@R153] and has the greatest relative increase in diabetes prevalence, with rates reaching 20% in Bahrain, Saudi Arabia and the United Arab Emirates.[@R153]^,^[@R154] In patients with type II diabetes, negative correlations with BMI and several lipid parameters, were reported in studies from Iran and Saudi Arabia.[@R133]^,^[@R139] Mean 25(OH)D levels were also low in subjects with metabolic syndrome and also negatively correlated with BMI, lipid parameters, blood pressure and indices of insulin sensitivity.[@R127]^,^[@R145] The relationship between vitamin D and cardiovascular diseases and mortality has been intensely scrutinized in western populations,[@R122] and examined in three studies from MENA ([Table 4](#T4){ref-type="table"}). In the Tehran Lipid Glucose study, subjects with 25(OH)D levels below 10 ng/ml, had an almost 3-fold higher risk of developing cardiovascular outcomes than those above 15 ng/ml.[@R129] In a small longitudinal study of 139 Iranian women admitted with acute myocardial infarction, 25(OH)D levels correlated with overall survival.[@R128] These findings were validated in large HMO population-based database from Israel, that demonstrated that patients with heart failure and 25(OH)D levels below 10 ng/ml, had an increased risk of mortality, HR 1.52 (95% CI 1.21−1.92) and that patients who took vitamin D, at doses of 800--1000 IU/day reduced mortality, HR = 0.68 (95% CI 0.54−0.85), at a median follow-up of 518 d.[@R143]

Lower 25(OH)D levels have also been described in subjects with Systemic Lupus Erythematosis (SLE) and negative correlations reported with several indices of SLE disease activity in patients from Iran, Egypt and Israel.[@R126]^,^[@R130]^,^[@R136] Associations with other rheumatologic conditions, musculoskeletal pain and fibromyalgia have also been described in patients from Egypt and Iran.[@R123]^,^[@R131] Mean 25(OH)D level was significantly lower in Egyptian patients with Hepatitis C Virus (HCV) infection than controls, measured at 10 ng/ml and negatively correlated with viral load and circulating levels of several interleukins.[@R124] Calcitriol also negatively correlated with interleukin levels in the same study subjects.[@R125] Lower 25(OH)D levels have also been noted in adults Iranian patients with multiple sclerosis,[@R155] and children suffering from Celiac Disease in Israel.[@R156] Only few are the studies that performed the necessary adjustments to identify the independent impact of vitamin D on health outcomes. Furthermore, association studies cannot control for all potential confounders and thus the lack of good evidence for a cause- effect relationship. For example obese subjects have low vitamin D and are also more likely to display the profile of metabolic syndrome, but that does not prove that low vitamin D is the cause for metabolic syndrome. Similarly, illnesses in general and cirrhosis in particular are conditions more likely to be associated with low vitamin D, but there is no good evidence for a causative effect for vitamin D in the illness. Thus there exists the need to rely on intervention studies, which are however scarce.

Intervention Studies
====================

Rickets
-------

A Cochrane review of four interventions trials enrolling around 1700 term infants, lasting between 9 mo and 2 y, showed that vitamin D at doses of 300−400 IU/day was sufficient to prevent rickets.[@R157]

Various regimens to treat rickets in the region have been described and were mostly conducted in non-randomized, non-blinded interventional studies. Treatment with a single intramuscular injection of vitamin D at doses of 150,000--600,000 IU, single oral doses between 50,000 IU and 600, 000 IU, daily injections or oral doses of 5,000 to 20, 000 IU for 1--3 mo followed by 400 IU daily maintenance, all revealed substantial improvement in biochemical, clinical and radiological features of rickets.[@R11]

In a dose ranging study of 52 Turkish infants with nutritional rickets and a mean age of 10 mo, subjects were randomized to receive one oral dose of vitamin D of 50,000 IU, 300,000 IU or 600,000 IU, and all received oral calcium for one week. On the 30th day there was no difference in the improvement between the three groups, and all patients had improved by the 60th day post-therapy, however, eight infants developed hypercalcemia, six of which were allocated to the high dose group.[@R158] The two most recent intervention studies conducted in ME are detailed in [Table 5](#T5){ref-type="table"} and confirm findings from previous studies as summarized above. Children with rickets from some countries in ME such as Egypt, Saudi Arabia and the United Arab Emirates have low calcium intake. Therefore, careful assessment of calcium nutrition and concomitant therapy with calcium, in cases from the region is indicated and would expedite clinical recovery.

Skeletal health in adults
-------------------------

The relationship between 25(OH)D levels and indices of bone and mineral metabolism, based on randomized controlled trials, are well established and extensively studied in western populations and to a lesser extent in other ethnic groups.[@R106] There are no such studies on subjects in the MENA region.

Skeletal health in children and adolescents
-------------------------------------------

The IOM report states that the Recommended Dietary Allowance (RDA) is the dose of vitamin D that would result in desirable 25(OH)D levels, above 20 ng/ml, in 97.5% of the population. . In children, the RDA is 600 IU/d.[@R16][Table 5](#T5){ref-type="table"} summarizes mean pre- and post-intervention 25(OH) D levels from recent studies in the region. The administration of doses of vitamin D, several folds above 600IU, fail to bring most subjects above the 20 ng/ml cut-off, presuming the same desirable level is needed across ethnic groups.

A recent meta-analysis of 6 randomized placebo controlled trials studies, concluded that it is unlikely that vitamin D supplements are beneficial to bone mass in subjects with normal 25 (OH)D levels.[@R159] However, planned subgroup analyses by baseline 25(OH)D level suggest that vitamin D supplementation of deficient children and adolescents could result in clinically useful improvements.[@R159] The latter was in large part driven by results from a randomized placebo controlled trial in 179 Lebanese girls, mean age 13 y, that showed a positive impact of vitamin D, administered weekly, at the equivalent daily doses of 200 IU and 2000 IU/day on musculoskeletal parameters in girls, including bone mineral content, density, area and lean mass, especially during the pre-menarcheal period.[@R100] A significant relationship between VDR genotypes and changes in bone mass at one year emerged and remained significant after adjustment for puberty, changes in lean mass, height and bone area.[@R160]

Maternal and neonatal health
----------------------------

There are very few studies evaluating effect of vitamin D on musculoskeletal outcomes in mothers or neonates. In a randomized controlled vitamin D trial, conducted in 2000 neonates in India, vitamin D administration at 35 µg/day (1400IU/day), significantly increased standard deviation (Z) scores for weight, length and arm circumference and decreased the proportion of children with stunted growth at 6 mo, but had no effect on death, hospitalization, in or out-patient visits.[@R161] Two on-going large multicenter trials, one conducted in US and the other in England, are evaluating the safety and efficacy of vitamin D administration, in pregnant mothers after the first term. The first uses doses of 400, 2000 to 4000 IU D /d until delivery,[@R162] and the second 1000 IU cholecalciferol/d or Placebo from 14 weeks gestation until delivery.[@R163] Considering the severe vitamin D deficiency in pregnant and lactating women in MENA, the gap in this field is substantial.

Metabolic syndrome
------------------

A close examination of individual randomized controlled trials investigating the effect of vitamin D supplementation (± calcium) on components of the MetS reveals negative findings for most trials, with the exception of the few that used high doses of vitamin D in high-risk individuals with obesity and insulin resistance at entry, but none was conducted in MENA.[@R152] In a study of 59 adult non diabetic, overweight and obese Saudis, advised to regularly expose themselves to sunlight and increase intake of vitamin D--rich foods, mean 25(OH)D levels increased from 7.6 to 11.2 ng/ml and the overall prevalence of MetS decreased from 25% to 13%, after one year.[@R145]

Infections
----------

Chronic infections are still prevalent in the MENA region. Strong associations between hypovitaminosis D and tuberculosis (TB) infection and acute lower respiratory tract infections have been reported in Indian, Turkish and Sub-Saharan African populations.[@R10] Although 25(OH)D levels below 20 ng/ml were associated with increased susceptibility to active TB in HIV-uninfected (n = 196) and HIV-infected (n = 174) black Africans in Cape Town, South Africa,[@R164] vitamin D supplementation failed to improve clinical outcome or mortality in a randomized placebo controlled trial of 126 subjects recruited from National Health Service in United Kingdom with active TB.[@R165] Vitamin D did not significantly affect time to sputum culture conversion in the whole study population, but it did significantly hasten sputum culture conversion in participants with the *tt* genotype of the TaqI vitamin D receptor polymorphism.[@R165] However, vitamin D supplementation contributed to accelerating resolution of inflammatory responses and sputum smear conversion during tuberculosis treatment.[@R166]

Conclusion
==========

Reports of nutritional rickets and osteomalacia occur in the MENA region, despite its plentiful sunshine and at much higher rates than in western countries. Hypovitaminosis, defined as a serum 25(OH)D below 20 ng/ml, is also prevalent across populations throughout the lifecycle, with proportions varying for the most part between 30--90%, depending on gender, season and lifestyle pattern. Population based studies are scarce, but results available from such studies validate the above observations. Genetic polymorphisms along the vitamin D pathway have been described mostly in western populations. The extent to which they account for low 25 (OH)D levels in the region awaits population-based genome wide association studies. There are large information gaps on what may constitute a desirable level for various health outcomes for subjects from this region. Furthermore, the recommended vitamin D doses by the IOM and even ES are sub-optimal to bring 25(OH)D to the putative "desirable" level in various age groups. Thus the pressing need to address such knowledge gaps, in order to facilitate the development of evidence-based region specific guidelines and to impact this subclinical condition that may be at the root of several chronic diseases.
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:   vitamin D
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